{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6usaALDA","lastupdate":"2023-10-11T00:00:00.000Z","update_date":"2023-10-11T00:00:00.000Z","lastModified":"Jul 30, 2025","active":1,"confidence_score":90,"confidence_score_reason":"founding month, markets, not claimed","urlname":"xylo-technologies","minimal_profile":null,"status":"Public","fullstatus":"Public on NASDAQ on Jul, 2015;Public on TASE on Mar, 2021;","acquired":0,"hide_reason":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","hide_reason_data":{"reason":"The company is a service provider","visible":0},"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$CEWwmu7lZFOsr6UiL4VFq0cUUUGgDI0bMB2NiSqr7IwTUzTi9aKOS0","name":"Xylo Technologies","oneliner":"Minimally Invasive Endosurgical and Imaging Tools","registrar":"512866971","website":"https://medigus.com","careerspage":"","founded_month":1,"founded_year":1999,"formernames":["Medigus"],"sociallinks":{"twitter":"https://twitter.com/medigus3","youtube":"https://www.youtube.com/user/medigus2013","facebook":"https://www.facebook.com/Medigusltd","linkedin":"https://www.linkedin.com/company/1385055","instagram":""},"social":["https://www.linkedin.com/company/1385055","https://www.youtube.com/user/medigus2013","https://www.facebook.com/Medigusltd","https://twitter.com/medigus3"],"flattenedsociallinks":"https://www.linkedin.com/company/1385055|https://www.youtube.com/user/medigus2013|https://www.facebook.com/Medigusltd|https://twitter.com/medigus3","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":24,"patent":1,"raised":77000000,"stage":"Public","public_stage":"Public","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Polyrizon"],"about":"Medigus is a technology-based company engaged in advancing innovative solutions for large-scale market applications.\r\n\r\nThe activities carried out by Medigus and its subsidiaries are focused on medical-related devices, products on the internet, other online-related technologies, and vehicle and wireless charging.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97286466880","country":null,"address":{"israeli":[{"id":"4293d6a9-7663-42aa-b5f5-f83454ef5fc8","city":"Omer","type":null,"address":"Omer, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"South District","news":[{"id":"E0GQ50GeuUYNG0Hf3envHGYVjZmLwYdxERI2n9jARfnt7Mrcaw5oS4","date":"Jun 6, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-says-viewbix-shares-133029585.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Public Trading","round":null,"company":"Xylo Technologies","layoffs":null,"summary":"Xylo Technologies announced that Viewbix, in which it holds an indirect stake, has received approval for its shares to be listed on the Nasdaq Capital Market. Viewbix shares are expected to begin trading under the symbol VBIX around June 5, 2025. Additionally, Xylo Technologies is set to be acquired by L.I.A Pure Capital, as approved by its shareholders. The company is also advancing in the EV charging sector with a new wireless system installation and has secured its first institutional client for the PORTO EV. These developments indicate a positive growth trajectory for Xylo Technologies.","partners":null,"customers":"PORTO EV","eventType":"IPO","investors":"L.I.A Pure Capital","confidence":9,"key_topics":["Nasdaq","Viewbix","Acquisition","EV Charging","Institutional Client"],"date_of_event":"June 6, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Public Trading","Acquired-by"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"using","structuredIssuesShow":"#Public Trading  #Acquired-by","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"H7hF5r1oDTx1CQAgNjih96GGhWBgBDBpj8p2yzLTMcuF65AVJKhncL","news_summary":"Xylo Technologies says Viewbix shares to begin trading on Nasdaq","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"gyGfx8vWf1q5UaJ9BCv2IMKf7g01nEBb38uXPuUq4nYLGrYL9flgw6","date":"Jun 5, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-viewbix-shares-begin-132100537.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":["investment","partnership"],"round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology company based in Israel, announced that Viewbix Inc., in which Xylo holds an indirect stake through its ownership in Gix Internet Ltd., has received approval for its shares to be listed on the Nasdaq Capital Market. This uplisting is seen as a significant milestone for Viewbix, which operates in the digital advertising space through its subsidiaries. Xylos strategic investment in Gix Internet supports Viewbixs growth and visibility in the capital markets. The event is expected to positively impact Xylo by enhancing its investment portfolio and partnerships.","partners":["Gix Internet Ltd.","Viewbix Inc."],"customers":null,"eventType":null,"investors":["Gix Internet Ltd."],"confidence":9,"key_topics":["Nasdaq","Viewbix","Gix Internet","advertising","technology"],"date_of_event":"June 5, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Partners"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EmdqKRvpYULPNhkOrEinO0tjvOHRQ5WXnz9P0NytvAp7DpSY35xsec","news_summary":"Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"QXSWewij8LIEouaQysDsjcSCdM09wbYnvBWTR8mVaTJxTRg81AZomk","date":"Apr 30, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-charging-robotics-successfully-131200635.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"EV charging","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its subsidiary Charging Robotics, Inc., has successfully installed a wireless charging system for electric vehicles in collaboration with a leading supplier of robotic parking facilities. This system, which integrates advanced machine learning and AI algorithms, addresses the challenges of EV charging in robotic facilities by enabling seamless and efficient charging. The solution is designed to optimize energy utilization and enhance user convenience, marking a significant step towards revolutionizing EV charging in automated parking environments. This development is expected to support the growing demand for space-efficient parking systems and sustainable urban living.","partners":"leading supplier of robotic parking facilities","customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["wireless charging","EVs","robotic parking","AI algorithms","sustainable living"],"date_of_event":"April 30, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Partners"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":"developing","structuredIssuesShow":"#Product Stage  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SMaKzxeWlkTBdySXea1lC522BFnH6hdViHunNro3c82g7wbX3pZPxb","news_summary":"Xylo Technologies: Charging Robotics Successfully Installs Wireless EV Charging System in Automatic Parking Facility","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"58OBVJk68xqOhBUdHYdLF5g11JKd29nUFeX11eT84qXXzahX6xlVD8","date":"Apr 29, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-revoltz-secures-first-103400473.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"commercial expansion","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its affiliate Revoltz Ltd., has secured its first institutional client for the PORTO EV, marking a significant step in its commercial expansion strategy. The institutional customer, a prominent logistics company, will integrate PORTO EVs into its urban delivery fleet, highlighting the growing demand for sustainable electric mobility solutions. This order follows Revoltzs successful launch of its commercial phase in Israel, which included a $2.7 million agreement for the delivery of 50 PORTO EV units to a local distributor. Xylo, traded on Nasdaq, focuses on innovative growth partnerships in medical solutions, digital commerce, and electric vehicles.","partners":null,"customers":"a prominent logistics company","eventType":null,"investors":null,"confidence":9,"key_topics":["electric vehicles","logistics","sustainability","urban delivery","commercial phase"],"date_of_event":"April 29, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"using","structuredIssuesShow":"#Customers  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pGve2vg6iJebY1umSn8p10zkrsbQ4lPrCfLmxR2H0XLwj32FLXHcOq","news_summary":"Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"VPOncMw3vngM5Szu025focK2smMHtjI4s2YVpRmqwyawX7QEQwfCyF","date":"Apr 10, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-revoltz-launches-commercial-132600955.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"commercial rollout","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd. has announced the first global commercial rollout of the PORTO EV, an electric micro vehicle designed for last-mile delivery, through its affiliate Revoltz Ltd. The rollout follows regulatory approval by the Israeli Standards Institute and marks the transition from development to deployment. Revoltz has delivered the first 50 units to its exclusive distributor in Israel as part of a five-year, $2.7 million distribution agreement, which includes an initial commitment of 150 vehicles in the first year. The distributor will manage sales, service, and maintenance, targeting local delivery fleets and small businesses. This move is seen as a significant step in meeting the rising demand for sustainable urban mobility solutions.","partners":"Revoltz Ltd., Charging Robotics, Inc.","customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["commercial rollout","electric vehicles","last-mile delivery","sustainability","urban transport"],"date_of_event":"April 10, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Customers","Partners"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Product Stage  #Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"PDwPwqlWI99chnzoQt6o3XqegZKXyv45M83aYmkXDr8JOspfkCBPYi","news_summary":"Xylo Technologies: Revoltz Launches Commercial Phase of PORTO EV in Israel with First 50 Vehicles Delivered to Exclusive Distributor","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8dCj6V2Y2qftlhYuEQo3WEiejOmlsUzNTSl48IxdvCxYhkHImkTbvb","date":"Apr 9, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-revoltz-wins-2025-121700649.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"innovation","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology company based in Israel, has announced that Revoltz Ltd., a company in which it holds a significant stake, has won the TAIPEI CYCLE d&i award 2025 in the Micro-Mobility category. This award is a prestigious international recognition for innovation and design in the bicycle and micro-mobility sector. Revoltzs product was showcased at the Taipei Cycle Show, a major B2B event in the cycling industry, emphasizing innovation and sustainability. Xylo Technologies, traded on Nasdaq, focuses on advanced medical solutions, digital commerce, and electric vehicle markets, with partnerships including Charging Robotics, Inc. and Revoltz Ltd.","partners":["Charging Robotics, Inc.","Revoltz Ltd."],"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["innovation","sustainability","micro-mobility","awards","technology"],"date_of_event":"April 09, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kdPAFl6It3MVG12UU5gVFOQQbm5lgNJtop7OOvNhXMHOZHrjpbU0L2","news_summary":"Xylo Technologies: Revoltz Wins 2025 TAIPEI CYCLE Award for Micro-Mobility Innovation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Z4il27PKO5EMQRlLRwavnOfWr3H3pi7sNMg7Jd8AeYSnQbc1LxfrZk","date":"Feb 4, 2025","link":"https://finance.yahoo.com/news/xylo-technologies-revoltz-receives-israeli-132800327.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"market-expansion","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its subsidiary Revoltz Ltd., has received approval from the Israeli Standards Institute to sell and market the PORTO EV micro vehicle in Israel. This approval is a significant milestone, allowing riders as young as 16 to operate the vehicle without a drivers license, thus lowering barriers to adoption. The PORTO EV is designed for last-mile delivery, offering robust design and functionality. Israels demand for eco-friendly transportation solutions makes it an ideal market for the PORTO EV. In 2023, Revoltz entered an exclusive $2.7 million distribution agreement with a premier distributor in Israel, which includes purchasing 150 vehicles in the first year. This development supports Charging Robotics goal of expanding its presence in the EV market.","partners":"Charging Robotics, Inc.","customers":"premier distributor in Israel","eventType":null,"investors":null,"confidence":10,"key_topics":["EV approval","last-mile delivery","micro-mobility","distribution agreement","sustainable transport"],"date_of_event":"February 4, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Customers","Partners"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Product Stage  #Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EQ9ifOoJlyeuc3z4oj8oMEmXoS98jaZNYXtIBLSuqMj6p2IHeNvPyE","news_summary":"Xylo Technologies: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9mioRBpbEMxJA58SeN4nRzG4otB4htvmiJyJ7V2sFFJ0jK3VGE5xfl","date":"Sep 27, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-first-half-2024-114247595.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"financial performance","round":null,"company":"Xylo Technologies","layoffs":null,"summary":"Xylo Technologies reported a significant decrease in revenue, down 64% from the first half of 2023, with a net loss of $8.17 million. Despite an improvement in loss per share, the companys shares have dropped by 15% over the past week. Looking forward, Xylo Technologies is expected to see a 34% annual growth in revenue over the next two years, outperforming the US Medical Equipment industrys forecasted growth of 8.1%. However, the article highlights potential risks, including four warning signs for the company. The analysis provided is based on historical data and forecasts, and does not constitute financial advice.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["revenue","net loss","share price","forecast","industry growth"],"date_of_event":"September 27th 2024","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"DuhL6qPVQltBsm4fxa4j7jW5mPMmAenXlHmYF99YTeYMqfNKlxfpQn","news_summary":"Xylo Technologies First Half 2024 Earnings: US$11.33 loss per share (vs US$13.39 loss in 1H 2023)","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"zty6tbRQOGgpdWvxHr1BBbKD01diG8GGAhWDBNokqbVxSFb37LRk9f","date":"Aug 15, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-parazero-received-order-132500966.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"partnership","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its affiliate ParaZero Technologies Ltd., has announced a new partnership with a leading Tier 1 defense OEM company to integrate its advanced drone safety systems for military and medical missions. ParaZero will initially provide 50 systems for testing, with plans for a larger pilot program upon successful validation. This collaboration aims to enhance medical field mission deliveries, particularly in remote areas, and underscores ParaZeros commitment to entering defense markets and improving healthcare logistics. The adapted systems are expected to enter commercial production by the end of 2024.","partners":"ParaZero Technologies Ltd.","customers":"Tier 1 defense OEM company","eventType":null,"investors":null,"confidence":10,"key_topics":["drone safety","medical delivery","partnership","defense market","technology integration"],"date_of_event":"August 15, 2024","product_stage":"testing","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"using","structuredIssuesShow":"#Partners  #Customers  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"mlkk2iMAiNE11UzAqgc7ZtieK0GxU8BA7fRcdbtnojFmFXcE2RiI5p","news_summary":"Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"QMkXQQfHy8B0hab8pExXZrbDrU4y27IE55wBcSRnaBvoKX9dRtQzZj","date":"Aug 14, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-revoltz-launch-innovative-132200994.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"innovation","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology company based in Israel, has announced the development of a new three-wheel electric cargo bike through its affiliate Revoltz Ltd. The bike is designed for the European and UK markets, offering enhanced stability, increased payload capacity, and advanced safety features. It aims to address urban transportation challenges and promote sustainable transportation. The bike combines manual and assisted pedaling, making it suitable for urban delivery services. The first prototype is expected within three months, with commercialization anticipated in early 2025. Xylos portfolio includes partnerships in advanced medical solutions, digital commerce, and electric vehicles.","partners":["Revoltz Ltd","Charging Robotics, Inc."],"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["electric cargo bike","urban transportation","sustainability","innovation","market expansion"],"date_of_event":"August 14, 2024","product_stage":"prototype","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"using","structuredIssuesShow":"#Product Stage  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"4XJDuXOaMpJMicPeLdDXmGn4jfFgfxN3ezS2b5Un23SxK4vekOA6N4","news_summary":"Xylo Technologies: Revoltz to Launch an Innovative Three-Wheel Electric Cargo Bike for European and UK Markets","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Uw8Mx8aCB4GMfp0uoGy4O7i3FwgVRDF90MelfXSupgxVsGO6D6OFbJ","date":"Jul 30, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-announces-plan-implement-200000263.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"ADS ratio change","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology company based in Tel Aviv, announced a reverse split of its American Depositary Receipt (ADR) program. Effective August 5, 2024, the ratio will change from 15 ordinary shares per ADS to 40 ordinary shares per ADS. This change will not affect the companys ordinary shares or share capital. The Bank of New York Mellon, as the depositary bank, will handle the exchange of ADSs. The reverse split aims to adjust the ADS structure without altering ownership percentages, except for minor adjustments due to fractional ADSs. Xylo is involved in advanced medical solutions, digital commerce, and electric vehicle markets.","partners":["Polyrizon Ltd.","Gix Internet Ltd.","Eventer Technologies Ltd.","Charging Robotics, Inc.","Revoltz Ltd.","Parazero Technologies Ltd.","Zig Miami 54 LLC"],"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["reverse split","ADS ratio","Nasdaq","BNY Mellon","technology"],"date_of_event":"August 5, 2024","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-neutral","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"none;"},"sentiment":"growth-neutral","analysisId":"CqzUuE4JIdskbIV3yc59qEwAJQnEscoWzgCvuwrD3b3VkrfDmpsYoi","news_summary":"Xylo Technologies Announces Plan to Implement ADS Ratio Change","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"RAfIYwNYKKl7bgADUB0BPishJU5o3JSltPJZaJA5C3CGwhxBXn3vT3","date":"Jul 23, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-charging-robotics-lands-122200799.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"innovation","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its subsidiary Charging Robotics, Inc., has received its first commercial order for a wireless charging system designed for automatic parking facilities. The order, placed by Parking Design Ltd., involves an initial batch of 12 systems and marks a significant step forward in the evolution of automated parking and EV charging technologies. Charging Robotics system uses machine learning and AI to optimize EV charging, addressing the growing demand for electricity. The collaboration with Parking Design is expected to enhance the efficiency and convenience of EV charging in automated parking environments, with systems scheduled to be operational by 2025.","partners":"Parking Design Ltd.","customers":"Parking Design Ltd.","eventType":null,"investors":null,"confidence":10,"key_topics":["wireless charging","EV technology","AI algorithms","automatic parking","sustainability"],"date_of_event":"July 23, 2024","product_stage":"pilot","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Customers  #Partners  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZlB0n79HojJeNmOvTk9y0mMEIVdlNS6uKQoe6HiemnmYBLmKmw2Gfm","news_summary":"Xylo Technologies: Charging Robotics Lands Commercial Order for EV Wireless Charging Systems in Automatic Car Parks","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"rdLZgFJu2uriDJnWCDMMQbyHTFIUFNOxek0mO1pTehd8QDRMsqwjBo","date":"Jun 27, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-charging-robotics-secures-121300483.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"innovation","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its subsidiary Charging Robotics Inc., has received its first commercial order for a wireless charging system designed for automatic parking facilities. The order, placed by Parking Design Ltd., marks a significant step in the evolution of automated parking and EV charging technologies. The system, which uses AI and machine learning algorithms, optimizes EV charging based on various parameters. This collaboration is expected to enhance the efficiency and convenience of automatic parking facilities. The order is scheduled for fulfillment throughout 2025, with the systems being integrated into Parking Designs facilities.","partners":"Parking Design Ltd.","customers":"Parking Design Ltd.","eventType":null,"investors":null,"confidence":10,"key_topics":["wireless charging","EV technology","AI algorithms","automated parking","sustainability"],"date_of_event":"June 27, 2024","product_stage":"pilot","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"0Rttg3FWwV4g665aRPrS8PDiok11mlHHgD5RKpeNru63dFwQKCVJe1","news_summary":"Xylo Technologies: Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems in Automatic Car Parks","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"vxySeUfiKxJzvieAkxcGyzBaXp1Fyka2txOtEVOB4wkdijQ5h1Z0Pj","date":"Jun 6, 2024","link":"https://finance.yahoo.com/news/xylo-gix-internet-signed-mou-132700928.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"partnership","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology-based company, announced that its affiliate, Gix Internet Ltd., has signed a non-binding memorandum of understanding (MOU) with a robotics company specializing in AI autonomous robotics solutions. The MOU outlines a share exchange transaction, which, upon completion, will make the Robotics Company a wholly owned subsidiary of Gix. This transaction is expected to provide Gix with opportunities for growth and technological advancements in AI and robotics. The shareholders of the Robotics Company will exchange their shares for 30% of Gixs shares, with options to increase their holdings upon achieving certain milestones. Xylo, traded on Nasdaq, focuses on innovative growth partnerships in medical solutions, digital commerce, and electric vehicles.","partners":["Gix Internet Ltd."],"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["AI","robotics","partnership","share exchange","subsidiary"],"date_of_event":"June 06, 2024","product_stage":"released","investment_date":null,"acquired_company":"Robotics Company","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Acquisition"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Partners  #Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7udrqvG54kZsWkRMrdV7LIZhOek85oyxApNip7MtR7bBPYIvfWEp6V","news_summary":"Xylo: Gix Internet Signed MOU for Investment and Merger with an AI- Robotics Company","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2lMlhtYdmAMuhkUX6VkOFy8Y5MLXdSutKOkGGRicdmjUXXDMaUHE6O","date":"May 28, 2024","link":"https://finance.yahoo.com/news/xylo-metagramm-successfully-completes-development-130000336.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"AI technology","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology company listed on Nasdaq, announced the successful development of Bubbl, an advanced writing tool by Metagramm Software Ltd., which is 19.99% owned by Xylo. Bubbl utilizes AI, Machine Learning, NLP, and Deep Learning to offer personalized and customized text writing, distinguishing itself from common AI writing tools. It supports multiple writing modes and caters to various profiles such as Business, Medical, Academic, and Blogging. The first version is set to launch for selected users in Q3 2024. Xylo is involved in various sectors, including medical solutions, digital commerce, and electric vehicles, with several affiliated companies.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["AI technology","writing tool","personalization","language translation","user experience"],"date_of_event":"May 28, 2024","product_stage":"completed development","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"lj3jpgsB62xOSfU2Re9Gwo8eiXoJrH89Hg3MzqSA0dpxhgqdjPkv6b","news_summary":"Xylo: Metagramm Successfully Completes Development of Advanced AI-Powered Writing and Grammar Product","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Feaxxq2b4v6avfUbyNLa6ta0BCxH575zallCYAazTOIfDMUTJJ0sR3","date":"May 21, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-signs-loi-acquire-125600519.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"acquisition","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., a technology-based company, has announced a letter of intent for the strategic acquisition of a leading German company specializing in AI predictive maintenance and condition monitoring technologies. This acquisition aligns with Xylos strategy to expand its portfolio in advanced AI technologies across various industries. The German company has been a leader in AI and machine learning for over a decade, providing services to sectors like aerospace, aviation, and transportation. Xylo will initially acquire 51% of the company for 1.5 million Euros, with the remaining shares to be acquired based on 2024 EBITDA results. This move is supported by Xylos newly appointed senior advisor, who brings extensive expertise in AI.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["AI technology","acquisition","strategic growth","predictive maintenance","senior advisor"],"date_of_event":"May 21, 2024","product_stage":"released","investment_date":null,"acquired_company":"a leading German company","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition","Management Changes"],"acquisition_amount":"1.5 million Euros","FDA approved/pending approval":null,"AI technology developing/using":"developing","structuredIssuesShow":"#Acquisition  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"AoT0Unlp66M4bHAlbfQXs7C7LB5TIDXLs91Iw3ECniMvkkgbfLJKHh","news_summary":"Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"zTKDPzQCD866mE8IbP0RJKcO2M3ntaM3U5kwcQMdb7hUhUAWJyTCGC","date":"May 15, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-charging-robotics-day-132200787.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"EV charging","round":null,"company":"Xylo Technologies Ltd.","layoffs":null,"summary":"Xylo Technologies Ltd., through its subsidiary Charging Robotics, Inc., has reached the final stages of developing a software for EV charging management in collaboration with Make My Day Ltd. The software, which uses AI and machine learning algorithms, aims to optimize electricity usage in automatic car parks by prioritizing EV charging based on various parameters. This development addresses the growing concern of electricity shortages for EV charging due to increased EV adoption. Charging Robotics has installed its wireless charging system in a pilot project in Tel Aviv, Israel. The collaboration with Make My Day is expected to add value for future customers by enabling efficient use of limited electricity supply.","partners":["Make My Day Ltd."],"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["EV charging","AI technology","wireless charging","partnership","pilot project"],"date_of_event":"May 15, 2024","product_stage":"pilot","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Partners  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YzXSo2lco9GdcqQC4KCemWCSkye6RcM22LCtT1YRdxQAPSdBaoZX0z","news_summary":"Xylo Technologies: Charging Robotics and Make My Day to Deploy AI based EV Charging Management System","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"AB9fsKk8hu5c2Z02xdOirXjCRu9WG4wnlhokMiCPCBHehe6O6Ft6lE","date":"Apr 22, 2024","link":"https://finance.yahoo.com/news/xylo-technologies-files-2023-annual-200500894.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Annual Report, Financial Statements","company":"Xylo Technologies Ltd.","layoffs":"Not mentioned","summary":"Xylo Technologies Ltd., previously known as Medigus Ltd., has filed its 2023 Annual Report on Form 20-F with the Securities and Exchange Commission. The report includes audited financial statements for the year ended December 31, 2023. Xylo is a technology-based company based in Israel, focusing on innovative growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets. The companys affiliations include Polyrizon Ltd., Gix Internet Ltd., Jeffs’ Brands, Eventer Technologies Ltd., Fuel Doctor, Inc., Charging Robotics, Ltd., Revoltz Ltd., Parazero Technologies Ltd., and Zig Miami 54 LLC.","partners":["Polyrizon Ltd.","Gix Internet Ltd.","Jeffs’ Brands","Eventer Technologies Ltd.","Fuel Doctor, Inc.","Charging Robotics, Ltd.","Revoltz Ltd.","Parazero Technologies Ltd.","Zig Miami 54 LLC"],"customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Annual Report","Financial Statements","Advanced Technologies","Affiliations","Investor Relations"],"date_of_event":"April 22, 2024","valuation_amount":"Not mentioned","impact_on_company":"Neutral","investment_amount":"Not mentioned","structured_issues":"Public Trading","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Public Trading","entityGrowthIconPath":"none;"},"sentiment":"Neutral","analysisId":"ypxUpxguqXrRBGO2RJl6XyWO1ikaH5eXICSZUULX0EwBDqxmayYIjI","news_summary":"Xylo Technologies Files its 2023 Annual Report on Form 20-F","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"xcJ5TjrMoFbrt4vcaVXk33cjBA2Xrt2Cx0ZPD7Ab0BY0Ma7oW1bFYR","date":"Apr 9, 2024","link":"https://finance.yahoo.com/news/medigus-announces-corporate-rebranding-changes-200300341.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Rebranding, Trading Symbol Change","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology-based company engaged in advanced innovative technologies, announced a corporate rebranding to reflect its current focus in innovation technologies. The company will change its name to Xylo Technologies Ltd and its Nasdaq trading symbol will change to XYLO. The rebranding includes a new name, an update to the company’s corporate logo, and a new website. The company will begin trading on the Nasdaq Capital Market under its new name and new trading symbol upon the opening of the market on April 18, 2024.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Corporate Rebranding","Innovation Technologies","Trading Symbol Change","Nasdaq Capital Market","Forward-Looking Statements"],"date_of_event":"April 09, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Management Changes"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KTDbfIBpUOHLDuEBaoPuCCWQatHiwB78SHvpPESJIGVqGw9UKz6ahc","news_summary":"Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"HzAhuVAvwPe3oVfePmNK5H5V4wASHNq4REXqQDl2w4d5Jz07yBTd9c","date":"Apr 1, 2024","link":"https://finance.yahoo.com/news/medigus-reaps-success-first-installation-114900133.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Technology, EV Charging","company":"Medigus Ltd.","layoffs":"N/A","summary":"Medigus Ltd., a technology-based company, has announced a significant achievement by its subsidiary, Charging Robotics Ltd., which has successfully installed its wireless charging system for an automated parking system (APS). This is reportedly the first installation of a wireless charging system for automatic car parks. The installation was in an automatic car park facility in Tel Aviv, Israel. The wireless charging system is intended to solve a problem for electric vehicles (EVs) parked in automatic car parks, which are in constant movement and thus prevent the use of charging cables.","partners":"Make My Day Ltd.","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Wireless Charging","Automated Parking System","Electric Vehicles","Technology","Innovation"],"date_of_event":"April 01, 2024","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Customers","Partners","Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Customers  #Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CJEOmhXtXbS6DFq3RE1Zy3x5QPMm8xLPwJeTUEvonBchZXAsCns3GL","news_summary":"Medigus Reaps Success with First Installation of a Wireless Charging System for Automatic Car Parks","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4dYOpHoIlTD6GGa18Nkqp2oC4D5X431ypJ8a7raN5ae0FD7Qwbg14X","date":"Mar 27, 2024","link":"https://finance.yahoo.com/news/medigus-revoltz-initiates-exclusive-distribution-115500328.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Electric Vehicles, Production, Distribution Agreement","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (EV) and charging solutions, announced that its EV joint venture, Revoltz Ltd, completed its first production batch of 50 units of its micro-mobility electric vehicle, ‘PORTO’. The completion of production is a significant step in enabling Revoltz to prepare for shipment of units in accordance with the Agreement signed over the past year. During 2023, Revoltz and a premier distributor in Israel entered into the Agreement, worth $2.7 million in revenue, with the goal to steer the advanced PORTO EVs into Israel and adjacent territories.","partners":"A premier distributor in Israel","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Electric Vehicles","Production","Distribution Agreement","Revenue","Last-mile Delivery"],"date_of_event":"March 27, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Partners","Customers"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"sf0FCrNTUFAes7XFaBKYDYlSu61LMreltS2OT8Q957buESCwqiLhtg","news_summary":"Medigus: Revoltz Initiates on Exclusive Distribution Agreement of $2.7 Million in Revenues and Completes the Production of the First 50 PORTO Micro-Mobility EVs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4pAhIRImiorcdKzF3TUJMUWsLSGlKjbN9mNMLYMJIw5txi1ALAwBqt","date":"Mar 19, 2024","link":"https://finance.yahoo.com/news/medigus-charging-robotics-announces-successful-132500554.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Technology, Electric Vehicles","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology-based company, announced that its subsidiary, Charging Robotics Ltd, has successfully installed its wireless charging system for an automated parking system (APS) in Tel Aviv, Israel. This is the first installation of a wireless charging system for automatic car parks. The system is designed to solve the problem of charging electric vehicles (EVs) in automatic car parks, where the constant movement of vehicles prevents the use of charging cables. The system was developed in cooperation with Make My Day Ltd.","partners":"Make My Day Ltd","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":"Wireless Charging, Automated Parking System, Electric Vehicles, Technology, Innovation","date_of_event":"March 19, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Customers, Partners","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"4xpjWVKRtSv152w6GTFEHIV2fxUiP4JQjoc53oRtcqc1BvCSr81FPy","news_summary":"Medigus: Charging Robotics Announces Successful Installment of its Wireless Charging System for Automatic Car Parks","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5VwI2lgoPv6WsFZxE6MTZlTCEQvaloV48XO9OBDcKGsW331BNSmZXo","date":"Feb 22, 2024","link":"https://finance.yahoo.com/news/medigus-parazero-ramps-partnership-us-123800829.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Collaboration, Drone Safety","company":"Medigus Ltd","layoffs":"N/A","summary":"Medigus Ltd, a technology company, announced that ParaZero Technologies Ltd, an aerospace company focused on drone safety systems and 18.68% owned by Medigus, has expanded its collaboration with Vayu Aerospace Corporation, a US-based drone original equipment manufacturer. ParaZero will customize its SafeAir system to be integrated at the design stage of Vayu’s G-1MKII VTOL aircraft. The two companies also have performance-based regulatory compliance testing and validation planned for the near future. The global market for VTOL unmanned aerial vehicles is projected to reach a size of $27.5 Billion by 2030.","partners":"ParaZero Technologies Ltd, Vayu Aerospace Corporation","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Drone Safety","Partnership","VTOL Aircraft","Regulatory Compliance","Aerial Solutions"],"date_of_event":"Feb. 22, 2024","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Partners","Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"83RxTsAlResxbi4g7enbz0GcCHwsqd4yF5fo1VSJi5woHikdwhFZrZ","news_summary":"Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Ncd6XnZTCL7Ka4ocpQ0CouYPh88FKR2UWjHibFpbTZDlGUGG9POwsp","date":"Jan 4, 2024","link":"https://finance.yahoo.com/news/medigus-revoltz-opens-pre-orders-124500272.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Electric Vehicles, Pre-orders","company":"Medigus Ltd.","layoffs":"Not mentioned","summary":"Medigus Ltd., a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, has announced the launch of pre-orders for the PORTO, an innovative electric vehicle (EV) from its subsidiary, Revoltz Ltd. The PORTO is designed for urban delivery solutions, combining long-range capability, robust design, and exceptional agility. This marks a significant step in Revoltzs commitment to offer sustainable, efficient and cutting-edge solutions for urban logistics.","partners":"Charging Robotics Ltd., Fuel Doctor Holdings, Inc.","customers":"Not mentioned","investors":"Charging Robotics Ltd., Fuel Doctor Holdings, Inc.","confidence":9,"key_topics":"Electric Vehicles, Pre-orders, Urban Logistics, Eco-friendly Transportation, Advanced Technologies","date_of_event":"Jan. 04, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Customers, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uxjfkupEGMolAwwFTBoMCR83MDWWB7boMY2gtO5X0r8awrGGT3fprn","news_summary":"Medigus: Revoltz Opens for Pre-Orders of its Revolutionary Micro Mobility EV","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"06ZRqmQ25DFKwYMWpvTaDlGDQCrHmbY6rjXJLLkR3csLAIl9YEyBSQ","date":"Dec 27, 2023","link":"https://finance.yahoo.com/news/medigus-charging-robotics-announces-positive-131000340.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Technology, Electric Vehicles","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced that its subsidiary, Charging Robotics Ltd, has completed a significant milestone towards the installation of its wireless charging system in automatic car parks. This is part of its pilot program with an automatic car park provider in Israel. The successful experiment involved transferring high voltage electricity in a wireless manner for electric vehicle charging. The next step is the full charging of an EV using the developed wireless charging system.","partners":"Charging Robotics Ltd, Fuel Doctor Holdings, Inc.","customers":"Not mentioned","investors":"Fuel Doctor Holdings, Inc.","confidence":9,"key_topics":["Wireless Charging","Electric Vehicles","Automated Parking","Technology","Investment"],"date_of_event":"Dec. 27, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Partners","Investment"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"dK8ELPWw3bIIb3KTfaTCH88uQ6SMcpsyqgeNBnZKClUiYWyZzsOFnb","news_summary":"Medigus: Charging Robotics Announces Positive Results in Transferring High Voltage Wireless Electricity Needed for EV Charging","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"IUo4QsBw8TmP2PJMCuGlTz9j42OXhQL7xQnGlJ8DSwEA1tqiT9vsYg","date":"Dec 26, 2023","link":"https://finance.yahoo.com/news/charging-robotics-subsidiary-medigus-secures-180841820.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Investment, Expansion","company":"Medigus Ltd.","layoffs":"Not mentioned","summary":"Medigus Ltd. has initiated a wireless EV charging pilot through its subsidiary, Charging Robotics Ltd. The project, which began in August 2023, is supported by funding from the Israel Innovation Authority. The wireless charging systems are designed for automated parking setups, addressing the lack of charging infrastructure in such environments. The funding, totaling approximately $445,000, is expected to drive substantial growth within the expanding Automated Parking System market, projected to reach $5.2 billion by 2032.","partners":"Not mentioned","customers":"Not mentioned","investors":"Israel Innovation Authority","confidence":9,"key_topics":["Wireless EV Charging","Automated Parking","Funding","Growth","Innovation"],"date_of_event":"August 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$445,000","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"IqXO8c2kZmSj4DL9mWlXV6BLYzd5i6vqFJ4QeJtgKvf7O97VscaVtk","news_summary":"Charging Robotics, A Subsidiary Of Medigus, Secures Israel Innovation Authority Funding For Wireless EV Parking Chargers","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"VB5JQ3LD0SqwDgT4XGNY2rK7pqny8QCRXcoepWPiOw30WpxaFfyOu2","date":"Dec 26, 2023","link":"https://finance.yahoo.com/news/medigus-charging-robotics-targets-1-121100493.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Investment, Innovation, Electric Vehicles","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, has announced the launch of a unique pilot of a wireless charging solution for electric vehicles (EVs) in automated parking systems. The project is led by Charging Robotics Ltd., a subsidiary of Fuel Doctor Holdings, Inc., which is owned by Medigus. The project received funding from the Israel Innovation Authority, with a total approved budget of approximately USD 445,000. The wireless charging system is designed to meet the growing demand for EV charging in automated parking systems.","partners":"Charging Robotics Ltd, Fuel Doctor Holdings, Inc.","customers":"Not mentioned","investors":"Israel Innovation Authority","confidence":9,"key_topics":["Wireless Charging","Automated Parking","Electric Vehicles","Funding","Innovation"],"date_of_event":"Dec. 26, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"USD 445,000","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"r4yRShv1LVSfn5300rcVN0xGpAfvOFxXadBZpIN2hWm8zixM5RPS7m","news_summary":"Medigus: Charging Robotics Targets the $1.8 Billion Automated Parking Market for EV Wireless Charging Solution","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1pjTul7BS9ic9chyIVuDqlCINZ23UUoLTFVpl4RcdZ6Rc7oOHkmPRQ","date":"Dec 21, 2023","link":"https://finance.yahoo.com/news/medigus-parazero-successfully-completed-drone-115900344.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Collaboration, Drone Safety","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies, announced the successful completion of its safety solution development for a Fortune 500 leading global automotive manufacturer’s proprietary drone program. The project was carried out by ParaZero Technologies Ltd, an aerospace company focused on drone safety systems for commercial drones and urban air mobility aircraft, which is 33.36% owned by Medigus. The successful completion of this project reinforces ParaZero’s reputation as a provider of advanced safety solutions across various aerial platforms.","partners":"ParaZero Technologies Ltd","customers":"Fortune 500 leading global automotive manufacturer","investors":"Not mentioned","confidence":9,"key_topics":["Drone Safety","Collaboration","Automotive Manufacturer","ParaZero Technologies","Payment"],"date_of_event":"Dec. 21, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"DaJ1nuFFlUvHMfVNneulpOSG1Kprub9cgci9xBLtJr1AmLCb8U3x4a","news_summary":"Medigus: ParaZero Successfully Completed its Drone Safety Project with a Fortune 500 Leading Automotive Manufacturer","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5yrw3m402AvcGgrIq2VjGL2vEv1D0koTRwhCTwZu6YpFUFqlFlkMeX","date":"Dec 18, 2023","link":"https://finance.yahoo.com/news/medigus-jeffs-brands-signs-non-134000880.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Investment, Technology","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company, announced that Jeffs Brands Ltd, a company in which it owns a 34.87% stake, has signed a non-binding letter of intent with Sky Growth Partners Ltd to invest in advanced laser-based wireless charging technology systems for drones and unmanned aircrafts. The investment will be used to establish a new Israeli company that will develop, manufacture and market the technology. Jeffs Brands will hold a 70% equity interest in the new company after an investment of $2.5 million.","partners":"Jeffs Brands Ltd, Sky Growth Partners Ltd","customers":"Not mentioned","investors":"Jeffs Brands Ltd","confidence":9,"key_topics":["Investment","Drones","Wireless Charging","Partnership","Technology"],"date_of_event":"Dec. 18, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$2.5 million","structured_issues":["Investment","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6lXO3xJtUVhM6if6w5Arzx3SvGEvdDsfhBvh1grsaGUIVvRs0l9zug","news_summary":"Medigus: Jeffs' Brands Signs a Non-Binding Letter of Intent to Invest in a Remote Wireless Electric Charging Technology Company","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bJlqBaHe3FlJB0cy3mu69Ra9RXryzdjXNcF1DEt8aViL1k9cEwyR4y","date":"Dec 14, 2023","link":"https://finance.yahoo.com/news/medigus-jeffs-brands-signs-non-210100917.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Investment, Partnership","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company, announced that Jeffs Brands Ltd, a data-driven E-commerce company owned 34.87% by Medigus, has entered into a non-binding letter of intent with Sky Growth Partners Ltd to invest in a Digital Light Processing (DLP) laser-based system for drone countermeasure solutions. The investment will be used to establish a new Israeli company that will develop, manufacture and market the technology. Jeffs Brands will invest $2 million and hold a 70% equity interest in the new company. The system will be used for defense and commercial applications.","partners":"Jeffs Brands Ltd, Sky Growth Partners Ltd","customers":"Not mentioned","investors":"Jeffs Brands Ltd, Sky Growth Partners Ltd","confidence":9,"key_topics":["Investment","Drone Countermeasure Technology","Partnership","Defense Sector","E-commerce"],"date_of_event":"Dec. 14, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$2 million","structured_issues":["Investment","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yBeuGHj8KmTOFPNLMfZ5kBgj9rvhC5i2aKewITGROVcFJpbLO927p1","news_summary":"Medigus: Jeffs' Brands Signs a Non-Binding Letter of Intent to acquire a 70% in a Laser-based Technology Company Developing Defense Solutions Against Drone-based Visual Systems","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ouKcavkBlEqnxZC0anXQlOarQtTIBxtq9rNjXrUfl6fICwSNm8H6Bg","date":"Nov 22, 2023","link":"https://finance.yahoo.com/news/medigus-charging-robotics-receive-funding-151000161.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Investment, Partners","company":"Medigus Ltd","layoffs":"N/A","summary":"Medigus Ltd, a technology company, announced that its subsidiary, Charging Robotics Ltd, has received approval for funding from the Israeli Innovation Authority for a pilot project. The project involves installing and demonstrating wireless charging solutions for electric vehicles in automated parking systems. The system will be tested in an automated parking system installed by Parkomot. The total approved budget for this project is approximately NIS 1.2 million ($445,000), of which the Israel Innovation Authority will finance 50%.","partners":"Parkomot Ltd","customers":"N/A","investors":"Israeli Innovation Authority","confidence":9,"key_topics":["Wireless Charging","Electric Vehicles","Funding","Innovation","Automated Parking Systems"],"date_of_event":"Nov. 22, 2023","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"$445,000","structured_issues":["Investment","Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"avLcMd5HfYEwZ465lcYAgRWRR1uzVM947r2biaY4FFmG7FzJGqKfjV","news_summary":"Medigus: Charging Robotics to Receive Funding from the Israel Innovation Authority for Piloting its Wireless Charging Solution for Automated Parking System","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fvRY6MS2K0St63ddKPC0j30dRrFnDTNKoiYIUcUiu6rpjL1Io0c2mG","date":"Nov 13, 2023","link":"https://finance.yahoo.com/news/medigus-metagramm-develop-bubbl-most-124500026.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Technology, Writing Tool","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company, announced that its subsidiary, Metagramm Software Ltd, is developing Bubbl, a state-of-the-art writing tool utilizing Machine Learning, Natural Language Processing (NLP), Artificial Intelligence (AI) and Deep Learning technologies. The Global Writing Enhancement Software market is expected to reach $887.9 million by 2030, and the company anticipates Bubbl to significantly impact this market. Bubbl offers a unique, user-friendly tool that enables users to enhance and re-write their text effortlessly, catering to a variety of writing needs with different profiles and features.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":"Machine Learning, Natural Language Processing, Artificial Intelligence, Deep Learning, Writing Enhancement Software","date_of_event":"Nov. 13, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6H5RWx7GGORyUxY2ULTkL2G6dEAVBP0cd0R2GoAyHUjRX0y68Aoihs","news_summary":"Medigus: Metagramm to Develop Bubbl,  its Most Advanced AI-Powered Writing and Grammar Tool","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"n8bh8RjLq5TUGkLNhWP9dUuw0IM6XASJsyhOodazlCchkSXNkSQRhE","date":"Oct 16, 2023","link":"https://finance.yahoo.com/news/medigus-revoltz-secures-exclusive-us-115500539.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"mjWCwJYxKDaOGUIT4TycKxLdbsyUcCJX6mUXF5ZN3GBm1fVgftTj48","news_summary":"Medigus: Revoltz Secures an Exclusive US Commercial Partnership with a Homeland Security Market Distributor","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"4drwoJ1b6z7jKLrg6SJQDOugWtCwE35D7tY8CRn1hp9Q7pyI3j2YPg","date":"Sep 28, 2023","link":"https://finance.yahoo.com/news/medigus-announces-53-3-million-211100059.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Financial Results, Mergers, Acquisitions, IPO","company":"Medigus Ltd.","layoffs":"Not mentioned","summary":"Medigus Ltd., a technology company engaged in innovative internet technologies, electric vehicle and charging solutions, and advanced medical solutions, has announced its financial results for the first half of 2023. The companys revenues reached $53.3 million, a 52% increase compared to the same period in 2022. Medigus subsidiary, Charging Robotics, merged with a US public company and commenced trading on the OTC Market. The company also sold its entire stake in Odysight.ai Inc. for approximately $5.7 million in cash. Additionally, ParaZero, a drone safety company, commenced trading on Nasdaq following a $7.8 million IPO.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Financial Results","Mergers","Acquisitions","IPO","Revenue Growth"],"date_of_event":"Sept. 28, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Investment","Acquisition","Public Trading"],"acquisition_amount":"$5.7 million","structuredIssuesShow":"#Investment  #Acquisition  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LjkYme6AR103g2MbDsZ3YVLvDUshUAjjKmwOBFyEp9zghOgwq8TcWE","news_summary":"Medigus Announces $53.3 million in Revenues for the First Six Months of 2023","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9aJN9pDr2DmkQKKJE033dcpvpjozCSFozaeHWlzaj2CAw30oGEhMGb","date":"Sep 28, 2023","link":"https://finance.yahoo.com/news/medigus-acquire-60-interest-commercial-132300016.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Acquisition, Expansion","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company, has announced its plans to establish a presence in Miami by acquiring, improving, renovating, developing, and selling commercial properties. The company has signed an operating agreement with a US-based partner for the formation of a joint venture that will purchase, renovate, manage, and sell a commercial property in Miami. The initial capital contribution paid by Medigus is $2 million and its initial percentage interest in the JV is 60%, while the Partner interest is 40%. Medigus intends to continue and explore additional opportunities in Miami for the purpose of acquiring, improving, renovating, further developing and selling the properties.","partners":"US-based partner specializing in acquiring, improving, renovating, developing and selling commercial properties in Miami","customers":"Not mentioned","investors":"Not mentioned","confidence":"10","key_topics":["Acquisition","Partnership","Investment","Expansion","Real Estate"],"date_of_event":"Sept. 28, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$2 million","structured_issues":["Investment","Partners","Acquisition","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Partners  #Acquisition  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"vGh6AMLSVXEeMr8TztJUpZ9w9CbvOxPNLErysy5ozgoh9x4sfdWXjG","news_summary":"Medigus to Acquire 60% Interest of Commercial Property in Miami","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"KuviVWi3q3gRVk44LBV6vPgwv812ICNAwB0BxedRXUnAyrXu3NBMh2","date":"Sep 12, 2023","link":"https://finance.yahoo.com/news/medigus-increase-share-ai-systems-120500012.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Investment, Acquisition","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, has converted a $1,240 thousand convertible loan into shares of AI Systems Ltd. Following the conversion, Medigus will hold a 36% stake in AI Systems and become its largest shareholder. AI Systems, a technology company traded on the Tel Aviv Stock Exchange, is in negotiations to merge new activity and further expand its technological endeavors.","partners":"AI Systems Ltd","customers":"Not mentioned","investors":"AI Systems Ltd","confidence":9,"key_topics":["Investment","Acquisition","AI Systems","Convertible Loan","Shareholder"],"date_of_event":"Sept. 12, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$1,240 thousand","structured_issues":["Investment","Acquisition"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QCVqTXaaXh142W71h5Qfzdw4VaOnvhrArqjB6YSLjNsWodFHhKe5jo","news_summary":"Medigus to Increase its Share in AI Systems to 36%","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"jIIGblIpaCwz4t6gcFXJJX4N15zF8g05KbMxbqI3636hFJGIxvxbYO","date":"Aug 21, 2023","link":"https://finance.yahoo.com/news/medigus-parazero-signs-development-agreement-113500766.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"expansion","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd announced that its subsidiary, ParaZero Technologies, has expanded into the Latin American drone market through a development agreement with Black Square, an industrial drone producer. Black Square will integrate ParaZeros patented parachute technology into its drone platforms to enhance safety. The collaboration solidifies ParaZeros commitment to promoting safety in the commercial drone and urban air mobility ecosystem in the region. ParaZeros SafeAir system offers a holistic safety approach for drone operations, ensuring a safe descent in the event of an emergency. The partnership with Black Square allows ParaZero to further its presence and deepen its ties in Latin America.","partners":"Black Square","customers":null,"investors":null,"confidence":8,"key_topics":["ParaZero Technologies","drone safety systems","Latin American drone market","development agreement","Black Square"],"date_of_event":"August 21, 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"JuaZo6tU7qn9Gc93ZvoLD8RXuZmdgCqBTipV1kkgWLOeTmcwCHcsaM","news_summary":"Medigus: ParaZero Signs New Development Agreement with Latin American Drone Manufacturer Black Square","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Nkxs6zyuaFYuRQtIUn53KnNGHMDQtsEUbr1lUxcKd7G0KHvoi5VnDh","date":"Aug 16, 2023","link":"https://finance.yahoo.com/news/medigus-viewbix-reports-condensed-consolidated-124700182.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"financial results","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd announced that its subsidiary Gix Internets 76% owned company Viewbix reported $48 million in revenue for the first half of 2023, representing an 18.5% increase in revenues compared to the second quarter of 2022. The increase in revenues was driven by Viewbixs digital content platform and search platform. Operating income for the first half of 2023 decreased compared to the previous year due to increased expenses related to a reorganization transaction and higher traffic-acquisition costs. EBITDA for the first half of 2023 also decreased compared to the previous year. Net cash from operating activities increased for the first half of 2023. Medigus is a technology company focused on advanced medical solutions, digital commerce, and electric vehicle markets.","partners":"Viewbix Inc.","customers":null,"investors":null,"confidence":8,"key_topics":["Financial results","Revenue growth","Operating income","EBITDA","Net cash from operating activities"],"date_of_event":"August 16, 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CgF4EvwvvoYTtNW7ug8i17WnZomG46Ogkg9fwG3VN2Vap4sHZ6EGwD","news_summary":"Medigus: Viewbix Reports its Condensed Consolidated Financial Results for the First Half and the Second Quarter of 2023 with Revenues Totaling $48 Million for the First Half of 2023","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ikEWv6GO0MrBwXdz57McurMbdIBmEkzroLpfd3JN902XeFG8CVxPjA","date":"Aug 14, 2023","link":"https://finance.yahoo.com/news/medigus-parazero-launches-safeair-m350-130500311.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":["drone safety","parachute system","technology","innovation"],"company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd announced the official release of the SafeAir M350 Pro, a parachute system designed for DJIs newest enterprise drone. The system is developed by ParaZero Technologies, an aerospace company focused on drone safety systems. Equipped with integrated sensors, the SafeAir system autonomously mitigates flight risks by cutting power to the drone, deploying a parachute, and bringing the drone to the ground safely. The system has received regulatory approvals for advanced operations and is available for purchase on ParaZeros website and through authorized distributors worldwide. Medigus Ltd is a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies.","partners":"ParaZero Technologies Ltd","customers":null,"investors":null,"confidence":8,"key_topics":["ParaZero Technologies","SafeAir M350 Pro","drone safety system","parachute technology","autonomous flight"],"date_of_event":"August 14, 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EC0MIfXyuQai4dWO5gAPZKrZYvSNw0D7dX9osAgiR5TJ475rZOz0Oc","news_summary":"Medigus: ParaZero Launches SafeAir M350 Pro for DJI's New Enterprise Drone","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"JyKRwPKVdP53Li1zpAhlRL0GdZZPw40iD5bZH04cn9Rr882VEXA05y","date":"Aug 8, 2023","link":"https://finance.yahoo.com/news/medigus-parazero-receives-second-order-130000331.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Drone Safety, Automotive Manufacturer","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company, announced that its aerospace company ParaZero Technologies Ltd has received a second order for its custom drone safety system from a major automotive manufacturer. The automotive manufacturer plans to integrate ParaZero’s SafeAir drone safety system into their proprietary aircraft from the design stage. This follows an agreement previously signed with the automotive manufacturer for the development of a bespoke safety solution for its proprietary drone program.","partners":"ParaZero Technologies Ltd","customers":"Fortune 500 automotive manufacturer","investors":"Not mentioned","confidence":10,"key_topics":["Drone Safety System","Automotive Manufacturer","Repeat Order","ParaZero Technologies","Proprietary Drone Program"],"date_of_event":"Aug. 08, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"q6tw25GQ4ZKJ4RSpfOPlGsNQxtJCvocpwhktg9jyDdRyWvQN74xRx0","news_summary":"Medigus: ParaZero Receives Second Order from One of the World’s Largest Automotive Manufacturers","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"FVGIIaKyRDDkB3mMKeVqiSuIWGUK1QZ13Q6GcaJvxIvLbr4vxc5DrU","date":"Aug 4, 2023","link":"https://finance.yahoo.com/news/medigus-charging-robotics-install-wireless-124500776.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Partnership, Technology, Electric Vehicles","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in electric vehicle charging solutions, announced that its subsidiary, Charging Robotics Ltd., received a Letter of Intent from an automatic car park provider in Israel to evaluate its wireless charging system for electric vehicles. The system is designed to meet the unmet need of charging electric vehicles in automatic car parks, which are gaining popularity due to their efficiency and cost-effectiveness. The wireless charging system offers seamless integration, a convenient charging experience, and scalability and adaptability.","partners":"Charging Robotics Ltd., Fuel Doctor Holdings, Inc.","customers":"Automatic car park provider in Israel","investors":"Not mentioned","confidence":9,"key_topics":["Wireless Charging","Electric Vehicles","Automatic Car Parks","Technology","Partnership"],"date_of_event":"Aug. 04, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Partners","Customers"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"H0FBYZS86KBKhSpDo9TP7alaekuH6g6L9piPSBfXRqgUSrIFvolDSp","news_summary":"Medigus: Charging Robotics to Install its Wireless EV Charging System with a Leading Automatic Carpark Provider","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Rrf8zrvstQNCHaNVUtUjwwjg8cqjSjkE6qpJixrGgNw6u6GSvGyNJd","date":"Jul 27, 2023","link":"https://finance.yahoo.com/news/medigus-drones-safety-company-parazero-130000040.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"RFBDQzt1eYf2KPiijtiCAbOavSBhDqld2mKWjal95Jb7OKYfzAOyeM","news_summary":"Medigus‘ Drones Safety Company, ParaZero (PRZO), to Commence Trading on Nasdaq Today","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"GAG7dtUje3ZyREVnLFCCKAXh25cAAzMOImJNLmCnjLUlXIV1Xfeod0","date":"Jun 6, 2023","link":"https://finance.yahoo.com/news/medigus-sells-entire-stake-scoutcam-124500824.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"sale of stake","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd has sold its entire stake in ScoutCam Inc. to existing shareholders and office holders, primarily to Mr. Mori Arkin, for approximately $6 million in cash. ScoutCam is a leading provider of Predictive Maintenance and Condition Based Monitoring solutions. The sale of the stake is a growth-negative impact on Medigus.","partners":"ScoutCam Inc.","customers":null,"investors":null,"confidence":8,"key_topics":["Medigus","ScoutCam","Predictive Maintenance","Condition Based Monitoring","Stake Sale"],"date_of_event":"June 06, 2023","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"fn1SQq5gTvgtsYNF59FjESIHxPiu4nRTB6cf8H75GiTpTMKKgAeo8i","news_summary":"Medigus Sells its Entire Stake in ScoutCam for Approximately $6 Million in Cash","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"zSj7MwjyHFNanz8phOXRBmD8T8W7aPKTJxQGHmyASNj28yDjLoSwHI","date":"May 16, 2023","link":"https://finance.yahoo.com/news/medigus-viewbix-reports-revenues-20-123800944.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"financial results","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd announced that Viewbix Inc, owned by Medigus subsidiary Gix Internet, reported consistent growth in revenues for the first quarter of 2023. Viewbixs digital content platform showed strong improvement in EBITDA. Revenues reached $20.9 million, with $15,752 thousand coming from the digital content platform. The operating loss for the quarter was $76 thousand. EBITDA amounted to $658 thousand. The companys net cash from operating activities was positive at $12 thousand. Medigus Ltd is a technology company focused on advanced medical solutions, digital commerce, and electric vehicle markets.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["financial results","revenues","EBITDA","digital content platform","operating loss"],"date_of_event":"March 31, 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5vqHPrbjVGZcFWVYdDxovR29ATWJZpF1AmFZEjDEkRssFVy8QLz3Lk","news_summary":"Medigus: Viewbix Reports Revenues of $20.9 Million in The First Quarter of 2023","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8OIRbqThsFHgfkBtnMCfXVdebkxMXxrG9hPaJ4x5tyZqUAmXCcC1nV","date":"May 6, 2023","link":"https://finance.yahoo.com/news/medigus-full-2022-earnings-us-121910883.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"financial results","company":"Medigus","layoffs":null,"summary":"Medigus reported its full year 2022 financial results, with revenue of US$91.9m and a net loss of US$9.82m. The companys shares are up 5.0% from a week ago. The article also mentions 2 warning signs for Medigus that investors should be aware of. It concludes with an invitation to join a paid user research session.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Financial results","Risk analysis","Warning signs","Feedback","Paid user research session"],"date_of_event":"2022","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"YDpeP3kc919EvdiEJdwBe1tLpxARb2rq5gRHkuUzizMU76RY4sy4ks","news_summary":"Medigus Full Year 2022 Earnings: US$6.04 loss per share (vs US$4.42 profit in FY 2021)","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"DWqFDzitcA1BaW3EqiU1MjiKCxUhyA2xcwoeC6HeEpRpTN3EPutWaX","date":"May 4, 2023","link":"https://finance.yahoo.com/news/medigus-announces-record-2022-financial-111100872.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"xJHVyafAtRG1Jh6VzUAytuvcHbn3xJfuFOiOugmkoRMpcQ7KBHkbRv","news_summary":"Medigus Announces Record 2022 Financial Results","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"iy4wFGGKGb1mBjUUopniqZmeLRnt2AC3KpcqhAhzcBL0DrNNMCvRgw","date":"Apr 27, 2023","link":"https://finance.yahoo.com/news/medigus-charging-robotics-ai-based-130000286.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"AIRGjz7h446MDLIbYveWlhIAIimspq5BqqhJYKKUM4KBv13KXchKlO","news_summary":"Medigus: Charging Robotics' AI Based Solution Ranked Among Top Outstanding Techpreneurs at the 14th Innovation World Cup","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"ZKkTYtLBLnXD91Sh36NAFUZaEX3gzEExVXNxTK20X06icwnA4RWxdv","date":"Apr 18, 2023","link":"https://finance.yahoo.com/news/medigus-subsidiary-ev-wireless-charging-121500406.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"txRLlFWPvxcfRqt8mb7n71s3cR0zKzb9XHvsmvH7oPSXOVjQGZPnVv","news_summary":"Medigus’s Subsidiary for EV Wireless Charging Merged with a Public Company in the US and Commenced Trading on the OTC Market","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"B7Af5JsmR1MfkhlBtjKFUHgS46sid3qUtPUViJ7LzoLB7WY4Tbps9n","date":"Apr 13, 2023","link":"https://finance.yahoo.com/news/medigus-acquires-19-9-innovative-124500250.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"LxpXvlQlZ0xHNsnGdpXDXLa3peiKp27go2RXrHYpPbjQxS3I6GF34Q","news_summary":"Medigus Acquires 19.9% of Innovative AI and Natural Language Processing Communication Based Software Company","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"IOSbRke96i1ZiCbhzuAP46NLCzOEZdiaSHkyUoo3JcfwV7teBpl7Xe","date":"Mar 27, 2023","link":"https://finance.yahoo.com/news/medigus-viewbix-reports-financial-results-123400774.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"NWBwd4k0oetcZUsN53NbPmjwq6AASDTZHv0y6gkH3viYPR0qiMjQf6","news_summary":"Medigus: Viewbix Reports its Financial Results for 2022 with a 114% Growth in Revenues Totaling $97 Million","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"4vcvRpeT9Gt5u2uiSaVK6mpMzPgLGhy0m19W1fqrLkS2f5Egb3lB5f","date":"Mar 21, 2023","link":"https://finance.yahoo.com/news/medigus-scoutcam-closes-14-million-131200198.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"k2AFpRA7zTHcxGWLESPYSi1KWdcUr3cTWPOjw63CuP4ZhkPrT5K8Qf","news_summary":"Medigus: ScoutCam Closes $14 Million Private Placement","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"FsbwOF1pex36uRZc0PFlT7ugG6D9iTQvYSGTcODkvD3yOyxME3XKC0","date":"Feb 23, 2023","link":"https://finance.yahoo.com/news/medigus-jeffs-brands-entered-non-134000339.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"vNzEQDCkZjwzx1DYurcTB9RP9EiGc2mUVMbRR68UIlyVL5tIs2Q8b2","news_summary":"Medigus: Jeffs' Brands Entered Into Non-Binding Letter of Intent with SuperBuzz for Developing AI-Based Software for Amazon’s Advertisement Platform","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"YaWWHCyAVQ3Oub2ThkRByRSPmReeZSqryJXwXfeWY6K9XwGPfzgJVO","date":"Feb 8, 2023","link":"https://finance.yahoo.com/news/medigus-elbit-systems-scoutcam-complete-131500233.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"PiCzQua4vgklpYafdTeGOOcAFt48nTkNmTKoofJCI2Z1eKMTDTCLXU","news_summary":"Medigus: Elbit Systems and ScoutCam Complete Major Development Stage in Real Time Video Monitoring Program","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"j3pVKd9S1rgeDaPh0uNLF6LTHbcyd2qn88NJiAAj3HFSvTNsKXKGXS","date":"Feb 7, 2023","link":"https://finance.yahoo.com/news/medigus-charging-robotics-nominated-submitted-133000376.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"gmCLSwZRAd1H7TGUAzSr6cv8NgNoqeJzjDXGUQMdxDweGGs5bsd7Au","news_summary":"Medigus: Charging Robotics was Nominated for and Submitted its AI based Solution to the 14th Innovation World Cup","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"S53IcjTJLJZZZrVQVy25aLaCakA1WiR6WYGZoe74k6voP5U09x50Pv","date":"Jan 30, 2023","link":"https://finance.yahoo.com/news/medigus-scoutcam-announces-1-45-133000437.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Partnership, Revenue Growth","company":"Medigus Ltd","layoffs":"N/A","summary":"Medigus Ltd, a technology company specializing in advanced medical solutions, internet technologies and electric vehicle charging solutions, announced that ScoutCam Inc, a company in which Medigus owns a 27% stake, has received an order from a leading US-based orthopedic healthcare corporation. The order is for ScoutCams video technologies and products to be integrated into a minimally invasive surgical device. The revenues from this partnership are expected to amount to $2.5 million in 2023, with potential for further growth in subsequent years.","partners":"ScoutCam Inc","customers":"US-based orthopedic healthcare corporation","investors":"N/A","confidence":9,"key_topics":["Medical Technology","Orthopedic Surgery","Revenue Forecast","Partnership","Innovation"],"date_of_event":"Jan. 30, 2023","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Customers","Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"qnx36Wo0wDd2AzBd2ZWXrj8A95hUH9o2GHsmp3SfOk8Xhmt3vgpLn0","news_summary":"Medigus: ScoutCam Announces $1.45 Million Order to Provide Miniature Camera Solution to Leading Fortune 500 Multinational Healthcare Corporation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"YeDoBobriiyqiDCimhnbyaFuf5f7pHJ6Dmea2kSSt8E77znKoDJMji","date":"Jan 26, 2023","link":"https://finance.yahoo.com/news/medigus-gix-media-increases-holdings-140000358.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Acquisition, Investment","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company, announced that its affiliate Gix Media Ltd has acquired an additional 10% of Cortex Media Group Ltd, increasing its holdings to 80%. The purchase was completed at a valuation of Cortex of approximately $27 million, for a consideration of $2.7 million in cash. This follows Gix Medias initial purchase of 70% of Cortexs share capital in October 2021. The increase in Cortexs current valuation is primarily due to an increase in its results and activity and its improved financials.","partners":"Gix Media Ltd, Cortex Media Group Ltd","customers":"Not mentioned","investors":"Gix Media Ltd","confidence":9,"key_topics":["Acquisition","Investment","Growth","Valuation","Finance"],"date_of_event":"Jan. 26, 2023","valuation_amount":"$27 million","impact_on_company":"growth-positive","investment_amount":"$2.7 million","structured_issues":["Acquisition","Investment"],"acquisition_amount":"$2.7 million","structuredIssuesShow":"#Acquisition  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KvIeTY2v6Wb3DFspkMdedJ7qyV06PSlWZg6Il32ERrnVInQGC1I3rU","news_summary":"Medigus: Gix Media Increases Holdings in Cortex Media Group to 80% of its Share Capital","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"yULetFD4sRsrXWSB320iQzopjofZhW5QxjjbZ1zOIlv9VPZYnjwKnd","date":"Jan 9, 2023","link":"https://finance.yahoo.com/news/medigus-eventer-technologies-signed-definitive-135500841.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":["merger","securities exchange","public company"],"company":"Medigus Ltd","layoffs":"N/A","summary":"Medigus Ltd announced that its subsidiary, Eventer Technologies, will merge with AI Conversation Systems, a company listed on the Tel-Aviv Stock Exchange. Eventer shareholders will hold 74.99% of the merged company. The merger will allow Eventer to become a public company and continue to grow in the conferences and events industry. The transaction is subject to closing conditions and Eventer must be valued at a minimum of $5.7 million. Eventer has developed an event management system that helps customers increase sales volume and reduce marketing resources. Medigus is a technology company focused on advanced medical solutions, digital commerce, and electric vehicle markets.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["merger","securities exchange","Eventer Technologies","AI Conversation Systems","Tel-Aviv Stock Exchange"],"date_of_event":"January 9, 2023","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Acquisition","Public Trading"],"acquisition_amount":"N/A","structuredIssuesShow":"#Acquisition  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"U8Z1jiEfMALCNM8w2spvKU8kmaDi8kxKjUgARzR13UJUKr4CB2xt3f","news_summary":"Medigus: Eventer Technologies Signed a Definitive Agreement for Reverse Merger to Become a Public Company","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Zgkzu2WHuGSG65DzWSN8R95CHLbfRjtKYq34IxTQjTYTPRsIZQhvIr","date":"Dec 8, 2022","link":"https://finance.yahoo.com/news/medigus-announces-details-1-6-124500255.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Cash Distribution, Tax Ruling","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced a $1.6 million cash capital distribution. The company will distribute cash capital of $0.85 per American Depositary Share (ADS) to ADS holders and holders of Nasdaq listed warrants, as of the record date of December 20, 2022. The payment is expected on or about December 28, 2022. The cash capital distribution is not subject to tax withholding in Israel.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":"Cash Capital, Tax Ruling, Advanced Medical Solutions, Electric Vehicle, Charging Solutions","date_of_event":"December 8, 2022","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"$1.6 million","structured_issues":"Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"20oDZ3WTh5CXtHuAzl4fYxal26ZSF42XmfugSzO8PLfk7bWsOYCWH4","news_summary":"Medigus Announces Details of its $1.6 Million Cash Capital Distribution","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"BMUnZjI0J4o5SCpUOAv8cq4VeTKvuISSE1y0Vrzj5ghpN3JiOUD2Kg","date":"Nov 30, 2022","link":"https://finance.yahoo.com/news/medigus-regains-compliance-nasdaq-minimum-141000110.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"upozR806JGILOros4f2Z8wfByBgFf5mEvXvdZ3vC5nLppoSkrGFkHe","news_summary":"Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"Wa3HwqvIhf9sWGkvLErh5EBjzuwb0qICrzupBCtOTiEx223QN7jJlD","date":"Nov 25, 2022","link":"https://finance.yahoo.com/news/medigus-charging-robotics-release-beta-133000298.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"wireless charging, electric vehicles","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd, through its subsidiary Charging Robotics Ltd, is set to release a beta version of a user interface application for its wireless charging robot. The app is being developed in collaboration with Make My Day, a company specializing in EV fleet management. The app will allow customers to order the charging service offered by the robots, receive billing information, driving instructions, and real-time data about EV electricity consumption and battery state of charge. The first product to be released by Charging Robotics will be a robot designed to automatically charge electric vehicles for disabled drivers. The system is expected to start pilot tests in Q1 2023. The Make My Day app will serve as the user interface for Charging Robotics, providing driving navigation algorithms and real-time communication with vehicles.","partners":["Make My Day"],"customers":null,"investors":null,"confidence":8,"key_topics":["Charging Robotics","Make My Day","user interface application","wireless charging robot","EV fleet management"],"date_of_event":"2022-11-25","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7JY4Uqpp4usE4x3rdGba9neXB0D89SCs5WVj05ep9MIVrWaftqbwYr","news_summary":"Medigus: Charging Robotics to Release a Beta Version of its User Interface by the End of the Year","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"z25f9Rr98mgHSwmUTGxXwMLBc7sXpAzTOKjkXLLswMdjCgKC8f0OyQ","date":"Nov 23, 2022","link":"https://finance.yahoo.com/news/medigus-viewbix-reports-record-revenues-140000434.html","source":"finance.yahoo.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"RCRzvBCD5KKHuWWrrEIN6kC4PbEEK2zfg7VjW01UjbeTlpKC3vxLnG","news_summary":"Medigus: Viewbix Reports Record Revenues of $66 million in the First Nine Months of 2022 Representing Increase of 176%","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"x2oScWDDBButSI11EZNVJExXUNj9lYEelMGgg5TyqfdlJPMqDX4TOP","date":"Nov 18, 2022","link":"https://finance.yahoo.com/news/medigus-announces-cash-capital-distribution-133000829.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"capital distribution","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd, a technology company engaged in advanced medical solutions, announced that the Tel Aviv District Court Economic Department has approved the companys motion for a cash capital distribution of up to $1.6 million. The companys board of directors has resolved to make a cash capital distribution of $1.6 million to the holders of the companys ADSs and eligible warrant holders. The distribution will be made in proportion to their respective holdings. The exact timing and details of the cash distribution will be announced separately. Medigus is focused on growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Capital distribution","Israeli court approval","Cash distribution","Technology solutions","Forward-looking statements"],"date_of_event":"2022-11-13","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KY5IVSfa3hgbtqxSgzF9P6da9V4znkdkg71LdeFfa9i89ymPaQaVa3","news_summary":"Medigus Announces Cash Capital Distribution of $1.6 Million","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"be4fd126-137f-4d3a-8397-e687ae43aaa8","date":"Mar 11, 2022","link":"https://www.globenewswire.com/news-release/2022/03/11/2401868/0/en/Medigus-Announces-Details-of-Planned-Spin-Off-and-Subsequent-Merger-of-its-EV-Wireless-Charging-Business.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"reverse merger","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd, a technology company, has announced that its subsidiary, Charging Robotics Ltd, has signed a non-binding letter of intent for a planned securities exchange agreement with Fuel Doctor, Inc. The agreement, if signed, will result in Charging Robotics becoming a wholly owned subsidiary of Fuel Doctor, with Medigus receiving 80% of Fuel Doctors share capital. Charging Robotics is developing an automatic wireless charging system for public parking lots, which aims to lower EV charging infrastructure installation costs. Medigus is focused on growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets. The transaction is subject to customary closing conditions.","partners":null,"customers":null,"investors":"N/A","confidence":9,"key_topics":["Charging Robotics","Fuel Doctor","Wireless charging","Electric vehicles","Medigus"],"date_of_event":"2022-03-11","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition","Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Acquisition  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"dz8hrmQKt591hCdKrI9gJ5qWid1mIdfMuT86VTnySbWTnToyD0cELT","news_summary":"Medigus Announces Details of Planned Spin-Off and Subsequent Merger of its EV Wireless Charging Business","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"249ef137-c8dd-4115-a523-8aa6b772588a","date":"Feb 8, 2022","link":"https://marketwirenews.com/news-releases/medigus-enters-psychedelics-market-with-investment-i-4875470839789777.html","source":"marketwirenews.com","visible":1,"analysis":{"tags":["investment","partners"],"company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has announced an expansion of its healthcare activities through an investment agreement with Clearmind Medicine Inc., a psychedelic pharmaceutical biotech company. Medigus will invest $1.25 million in exchange for approximately 2 million units of Clearmind, representing 5.02% of the company. Clearmind focuses on the discovery and development of psychedelic-derived therapeutics for mental health and other health problems. The two companies also plan to form a joint venture in the food industry based on Clearminds intellectual property. Medigus will be issued shares and warrants as part of the agreement. The investment amount will be paid in cash and through the issuance of Medigus American Depository Shares. Medigus will also be entitled to 10% of the initial equity of a potential venture in the psychedelics area. The agreement aims to capitalize on the growing market for psychedelic drugs.","partners":["Clearmind Medicine Inc."],"customers":null,"investors":"Clearmind Medicine Inc.","confidence":9,"key_topics":["expansion","investment agreement","psychedelic pharmaceuticals","joint venture","patent portfolio"],"date_of_event":"2022-02-08","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1.25 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yomRzxVx2IJVQlIk00VKIUj3AvSoXyM9U975vcry5ScGgMAyMKdApB","news_summary":"Medigus Enters Psychedelics Market with Investment in Clearmind a Psychedelic","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0c008e73-27fe-4ffa-9f04-4d87859f621e","date":"Jan 8, 2021","link":"https://www.globenewswire.com/news-release/2021/01/08/2155550/0/en/Medigus-Enters-the-Wireless-Charging-Market-for-Electric-Vehicle-with-New-Autonomous-Technology.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"acquisition","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus has entered into an agreement to acquire IP and know-how, including a provisional patent, for a wireless robotic charging pad for electric vehicles. The company plans to invest in the initial development of the technology and consolidate its electric vehicle and wireless charging activities under a new subsidiary. The acquisition is expected to have a positive impact on the companys growth.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Medigus","electric vehicles","wireless charging","IP acquisition","technology development"],"date_of_event":"January 8, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$75,000","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NKWgP5zJVHXw4myAAn1tzBcuRnCjUySJpTPJMxzqAjYx9zmRiP5m9O","news_summary":"Medigus Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6afdbb55-3f73-4206-80de-f16b8d421dfc","date":"Jan 4, 2021","link":"https://www.globenewswire.com/news-release/2021/01/04/2152689/0/en/Medigus-closes-an-investment-in-Smart-Repair-Pro-and-Purex-each-Operating-on-the-Amazon-Marketplace.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"acquisition","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd has announced the acquisition of controlling interest in Smart Repair Pro, Inc. and Purex, Corp, two data-driven e-commerce companies operating on the Amazon Marketplace. Medigus now owns approximately 50.01% of the issued and outstanding share capital of each company. Smart Repair Pro and Purex achieved over 214% growth in revenues in 2020 compared to 2019, with approximately $2.2 million in revenues in 2020. Smart Repair Pro also plans to launch a new brand and product line on the Amazon Marketplace and pursue a Business-to-Consumer (B2C) business model with a direct sales channel. Medigus is a technology company engaged in advanced medical solutions and innovative internet technologies.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["revenue growth","acquisition","Amazon Marketplace","new brand launch","B2C business model"],"date_of_event":"2021-01-04","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":null,"structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"a71aCqtlY3RxLkbD8Y3TbfXCyvrUsxtVbMgswNkpny1WKHSaXIYpEu","news_summary":"Medigus closes an investment in Smart Repair Pro and Purex, each Operating on the Amazon Marketplace","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d25e370e-c4d5-4edf-a48f-061506c8bdb0","date":"Oct 16, 2020","link":"https://www.globenewswire.com/news-release/2020/10/16/2109829/0/en/Medigus-to-Acquire-Control-of-Automated-Online-Offline-Ticketing-Platform-Company-Eventer.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"investment, partnership","company":"Medigus Ltd","layoffs":"","summary":"Medigus Ltd has announced the signing of a share purchase agreement and revolving loan agreement with Eventer Technologies Ltd. Medigus will invest up to $1,000,000 in Eventer and loan up to an additional amount of $1,250,000. Upon closing, Medigus will hold 50.1% of Eventers share capital. Eventer is a company engaged in providing interactive automated online & offline enterprise ticketing and events platform. Medigus believes that it has invested in an effort to further promote Eventers penetration and expansion into target markets, primarily in North America. Eventers clients include leading production companies, Israeli Electric Corporation, American Express, Live Nation, and more.","partners":"Eventer Technologies Ltd","customers":"","investors":"","confidence":8,"key_topics":["Medigus","Eventer Technologies","share purchase agreement","revolving loan agreement","investment"],"date_of_event":"2020-10-16","valuation_amount":"","impact_on_company":"growth-positive","investment_amount":"$1,000,000","structured_issues":["Partners"],"acquisition_amount":"","structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CpMk9iNNjzrQ5DL6u8ED6hsyDk2P3YcvBkKF7AMbG3jwZgyz8LZwg6","news_summary":"Medigus to Acquire Control of Automated Online & Offline Ticketing Platform Company Eventer","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"3c740976-89d0-48b0-a27f-c9e3dbfdede6","date":"Oct 9, 2020","link":"https://www.globenewswire.com/news-release/2020/10/09/2106265/0/en/Medigus-Enters-E-Commerce-Brands-Marketing-on-Amazon-Marketplace.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"Acquisition, Investment","company":"Medigus Ltd","layoffs":"Not mentioned","summary":"Medigus Ltd, a technology company engaged in advanced medical solutions and innovative internet technologies, has announced its entry into e-commerce business by signing a definitive agreement to acquire a controlling interest in Smart Repair Pro, Inc. and Purex, Inc., two data-driven e-commerce companies, operating on the Amazon Marketplace. Medigus will hold 50.01% of the issued and outstanding share capital of each of the companies, acquired through a combination of a cash investment in the companies, and an acquisition of additional shares from the companies’ current shareholders in consideration for restricted ADSs of Medigus and a cash component.","partners":"Smart Repair Pro, Inc. and Purex, Inc.","customers":"Not mentioned","investors":"Not mentioned","confidence":"9","key_topics":"E-commerce, Acquisition, Investment, Amazon Marketplace, Medical Solutions","date_of_event":"October 09, 2020","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$1,250,000","structured_issues":"Acquisition, Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Acquisition, Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Zvuc25BZoFwEjwm4oas7hiSb1Gy02LZoRNaF6Taqi6gZK7uPIGdDhB","news_summary":"Medigus Enters E-Commerce Brands Marketing on Amazon Marketplace","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"aff3d618-26e4-4dbc-a91a-7d6576aa986a","date":"Jul 24, 2020","link":"https://www.globenewswire.com/news-release/2020/07/24/2067229/0/en/Medigus-ScoutCam-Announced-Acceptance-of-2-4M-Quote-from-a-Fortune-500-Multinational-Healthcare-Corporation.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Medigus Ltd","layoffs":null,"summary":"Medigus Ltd announced that its subsidiary, ScoutCam Ltd, accepted a quote of $2.4 million for its single-use miniature video cameras from a Fortune 500 multinational healthcare corporation. The two companies will work together to develop a complete visualization solution for a minimally invasive surgical end-user product. The partnership is expected to generate tens of millions of dollars in revenue per year. ScoutCam is a leading provider of customized visual solutions, while Medigus is a technology company developing minimally invasive tools and direct visualization technology.","partners":"ScoutCam Inc.","customers":"Fortune 500 multinational healthcare corporation","investors":null,"confidence":9,"key_topics":["Customized Products","Medical Supplies","Visual Solutions","Minimally Invasive Tools","Direct Visualization Technology"],"date_of_event":"July 24, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"a8YFXHb01mVAJpGpzvmu69kgtxGI1KvlZMqO176Zgn2DJFtPWZiU5H","news_summary":"Medigus: ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fd801f1d-6e07-4058-9989-3976b149e079","date":"Jan 10, 2019","link":"https://www.einnews.com/pr_news/473295928/medigus-announces-ceo-chris-rowland-to-step-down","source":"www.einnews.com","visible":1,"analysis":{"tags":"management changes","company":"Medigus","layoffs":null,"summary":"Medical device company Medigus announced that its CEO, Chris Rowland, will step down effective February 28, 2019. Rowland will continue to work with the company as a consultant. An executive committee will take over Rowlands responsibilities until a replacement is appointed. Medigus specializes in developing minimally invasive endosurgical tools and innovative imaging solutions. The companys flagship product is the MUSE system, used for the treatment of GERD. Medigus is traded on the Nasdaq Capital Market and the TASE. The CEOs resignation is a growth-negative impact on the company.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["CEO Resignation","Company Products","Medical Device","Endosurgical Tools","Direct Visualization Technology"],"date_of_event":"2019-02-28","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"zL6jtrKx6wgQrvPYfzWm8cXklsdeFTgkFbofwwpshqVDeAe02bGFhE","news_summary":"Medigus Announces CEO Chris Rowland to Step Down","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"79a7e2f2-645a-4e1d-ba6d-9f8ef47ef79c","date":"Dec 18, 2018","link":"https://en.globes.co.il/en/article-medigus-in-advanced-talks-to-license-reflux-treatment-device-1001265380","source":"en.globes.co.il","visible":1,"analysis":{"tags":"medical device","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. is in advanced negotiations with multinational companies to license its MUSE reflux treatment technology worldwide. The company expects to receive upfront payments worth millions of dollars. The MUSE system is an FDA and CE approved endoscopic device for the treatment of GERD.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["MUSE technology","reflux treatment","licenses","multinational companies","upfront payments"],"date_of_event":"December 18, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zwWSiCwTy7c5CsFIvaILOvul36Iq3rCeNGAH0xP9aR8GhO2i6CIb8T","news_summary":"Medigus in advanced talks to license reflux treatment device","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5a58f623-8a33-4312-afb6-f4d9750b00ec","date":"Dec 6, 2018","link":"https://globenewswire.com/news-release/2018/12/06/1663037/0/en/NASA-Deploys-Medigus-micro-ScoutCam-Miniature-HD-Camera-During-Robotic-Refueling-Mission.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"space technology","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has announced that NASA has incorporated its micro ScoutCam™ 8.0 HD camera into its Visual Inspection Poseable Invertebrate Robot 2 (VIPIR2). The camera will be used as part of NASAs Robotic Refueling Mission 3 (RRM3), which aims to test tools and technologies for refueling and repairing satellites in orbit. This collaboration is the result of an official tender bid with the United States government. Medigus is honored to support NASA on RRM3 and believes its innovative technology will greatly contribute to the mission. The micro ScoutCam™ 8.0 HD is custom designed for NASA and features a miniature size, remarkable image quality, customizable optics, waterproof materials, and adaptability in extreme temperatures.","partners":"National Aeronautics and Space Administration (NASA)","customers":null,"investors":null,"confidence":9,"key_topics":["NASA","micro ScoutCam™ 8.0 HD","Robotic Refueling Mission 3","custom-tailored optics","camera inspection capabilities"],"date_of_event":"December 5, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"C0n7aZ4jIDfk87mTFAKCFsZwkeVCvJ1y15WsmQ28sBtNRFTIzrHlI5","news_summary":"NASA Deploys Medigus' micro ScoutCam™ Miniature HD Camera During Robotic Refueling Mission","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e67b1abb-a3dc-4e7e-a442-c9cad568876f","date":"Aug 5, 2018","link":"https://en.globes.co.il/en/article-medigus-signs-us-reflux-device-distribution-deal-1001248848","source":"en.globes.co.il","visible":1,"analysis":{"tags":"distribution agreement","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has signed an exclusive distribution agreement with Micro-Tech Endoscopy USA for its Medigus Ultrasonic Surgical Endostapler (MUSE) system in the US for the treatment of heartburn. The agreement is for an initial term of three years with annual increases in minimum purchases for the first seven years. Medigus also has an exclusive distribution agreement with Micro-Tech Europe for the MUSE system in Germany.","partners":"Micro-Tech Endoscopy USA, Inc.","customers":null,"investors":null,"confidence":9,"key_topics":["Medigus Ultrasonic Surgical Endostapler (MUSE) system","Micro-Tech Endoscopy USA","heartburn","distribution agreement","reimbursement"],"date_of_event":"August 5, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3AS8YjgTiaNkCzt1Q4K92uvHu3HY5TtLHQta1cvIOVagF4mlbLHbao","news_summary":"Medigus signs US reflux device distribution deal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4f5f240e-9f59-4b8f-9713-96f67a051d9b","date":"Jul 24, 2018","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3742967,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"medical device","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has raised $10 million in an underwritten public offering. The company develops minimally invasive endosurgical tools and direct visualization technology, including the FDA-cleared MUSE system for the treatment of gastroesophageal reflux disease. The offering consisted of 2,837,674 units at a price of $3.50 per unit. Each unit includes one American Depositary Share (ADS) and one Series C warrant to purchase one ADS. The Series C warrants began trading on the Nasdaq. Medigus is a Nasdaq and Tel Aviv-listed medical device company based in Omer, Israel.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Medigus","minimally invasive endosurgical tools","direct visualization technology","public offering","MUSE system"],"date_of_event":"24.07.18","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CsmUErxZZZf2XRg6R5oktNnX5L3YLvOBJPeqBoinegLwW2LrBRTeUk","news_summary":"Medical Device Company Medigus Raises $10 Million in Public Offering","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"81a2e98d-0850-406d-a6ae-eb6e3d46ba56","date":"Jun 27, 2018","link":"http://en.globes.co.il/en/article-medigus-jumps-on-orthopedic-agreement-1001243442","source":"en.globes.co.il","visible":1,"analysis":{"tags":"development agreement","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has entered into a development agreement with A.M. Surgical, Inc. to develop and manufacture an integrated visualization device based on its micro ScoutCam technology. The agreement requires Medigus to provide prototypes and production of the device, with a total project budget of $780,000. The device has the potential to offer a higher level of surgical control and visualization during endoscopic carpal tunnel release procedures. Medigus CEO Chris Rowland expressed satisfaction with the partnership, while A.M. Surgical CEO Ather Mirza highlighted Medigus research and development proficiency. The agreement is expected to contribute to the growth of Medigus Ltd.","partners":"A.M. Surgical, Inc.","customers":null,"investors":null,"confidence":9,"key_topics":["Medigus","A.M. Surgical","development agreement","visualization device","micro ScoutCam technology"],"date_of_event":"June 27, 2018","valuation_amount":"$5.58 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nyIusGBTmWA1PCi2A2AKP62pM0T6L4BpTg7keWneuwQ78V8IhdYHc0","news_summary":"Medigus jumps on orthopedic agreement","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a7dc33e4-3f6d-4b02-88e0-209edca787ea","date":"May 30, 2018","link":"https://globenewswire.com/news-release/2018/05/30/1514266/0/en/Medigus-to-Present-New-Data-On-The-MUSE-System-at-Digestive-Disease-Week-DDW-2018.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"clinical research","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd., a medical device company, announced that new data from its clinical research on the MUSE system will be presented at Digestive Disease Week. The MUSE system is a minimally invasive endosurgical tool used for the treatment of gastroesophageal reflux disease (GERD). The data highlights the safety and efficacy of the MUSE system, which offers an incision-less procedure for GERD patients. The company remains dedicated to building on its clinical success. The poster presentations will take place on June 2-5, 2018 in Washington, DC.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["MUSE system","clinical research","GERD","endosurgical tools","poster presentations"],"date_of_event":"2018-06-02","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"80dJGmYCijXHPXysIt5y92VGvGusUgJvVPo69QJYQOl0KnSLMAjV32","news_summary":"Medigus to Present New Data On The MUSE™ System at Digestive Disease Week® (DDW) 2018","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ae3e0457-8867-4534-81f9-d6b75e33c290","date":"May 14, 2018","link":"https://globenewswire.com/news-release/2018/05/14/1502046/0/en/Medigus-Broadens-Availability-of-MUSE-Through-Distribution-Agreement-with-MELEKIRMAK-in-Turkey-Azerbaijan-and-Georgia.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"distribution agreement","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has announced a distribution agreement with MELEKIRMAK in Turkey, Azerbaijan, and Georgia. The agreement requires MELEKIRMAK to purchase a minimum of approximately EUR 1 million of Medigus Ultrasonic Surgical Endostapler (MUSE) equipment over five years. The MUSE system is a single-use flexible transoral stapler used to treat GERD. Medigus aims to provide a more cost-effective and minimally invasive option for GERD treatment. The company is focused on gaining MUSE adoption in key markets worldwide.","partners":"MELEKIRMAK","customers":null,"investors":null,"confidence":8,"key_topics":["distribution agreement","minimally invasive medical devices","GERD treatment","MUSE system","Medigus"],"date_of_event":"May 1, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"I4pThuT2oQUi88QN5eSu4I9CoIuuTdnDYOG5WyazMKRcQkh2cDEL4Y","news_summary":"Medigus Broadens Availability of MUSE™ Through Distribution Agreement with MELEKIRMAK in Turkey, Azerbaijan and Georgia","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"21b98123-9e94-4efb-854c-1196d8664009","date":"Apr 17, 2018","link":"https://globenewswire.com/news-release/2018/04/17/1480503/0/en/Medigus-and-HC-Marbella-International-Hospital-Announce-First-MUSE-Procedure-for-GERD-Treatment-in-Spain.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"medical device","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd., a medical device company, announced the completion of the first MUSE procedure in Spain. The procedure was successful and the patient was released from the hospital. The MUSE system is a single-use flexible transoral stapler used to treat gastroesophageal reflux disease (GERD). The device requires no incisions, resulting in greater patient comfort and reduced hospital stays. Medigus aims to expand availability of the MUSE procedure in other areas of Europe in the future. The company specializes in developing minimally invasive endosurgical tools and imaging solutions.","partners":["High Care Marbella International Hospital"],"customers":null,"investors":null,"confidence":9,"key_topics":["MUSE procedure","GERD","medical device","endoscopic device","minimally invasive"],"date_of_event":"April 17, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2J6JSzHn4DFeh33fvZe2BNCarPreLdC1MI4vfGqta0mJyvjJqxGpET","news_summary":"Medigus and HC Marbella International Hospital Announce First MUSE™ Procedure for GERD Treatment in Spain","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b1db440a-171a-4d0b-b417-32f6dd1df106","date":"Dec 3, 2017","link":"https://globenewswire.com/news-release/2017/12/04/1216468/0/en/Medigus-Announces-Distribution-Agreement-with-Micro-Tech-Europe-for-the-MUSE-System-in-Germany.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"distribution agreement","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has announced a five-year distribution agreement for its MUSE System in Germany with Micro-Tech Europe. Under the agreement, Micro-Tech Europe will be the exclusive distributor for the MUSE System in Germany. The MUSE System is a medical device used for incisionless transoral fundoplication, a procedure to treat GERD. Medigus is pleased to have Micro-Tech Europe as a partner and believes the agreement will help expand market access and drive sales of the MUSE System. Micro-Tech Europe shares Medigus commitment to innovation and high-quality products. The distribution agreement is a growth-positive development for Medigus.","partners":"Micro-Tech Europe","customers":null,"investors":null,"confidence":9,"key_topics":["distribution agreement","MUSE System","GERD","Micro-Tech Europe","medical device"],"date_of_event":"December 3, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nwv16HEnBvpctZTJEfXpl7cC5RfO4SETLoFLmN1lvhppaWMk3vFWWS","news_summary":"Medigus Announces Distribution Agreement with Micro-Tech Europe for the MUSE™ System in Germany","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"38d719e8-ff81-439d-88eb-b826743346ee","date":"Mar 26, 2017","link":"http://www.globes.co.il/en/article-medigus-raises-nis-75m-on-nasdaq-share-plunges-1001182598","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical devices, fundraising, market penetration","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd., a medical devices company, raised $7.5 million on Nasdaq for its non-surgical treatment for GERD. However, the companys market cap is currently half the amount it raised. Medigus is facing difficulty in penetrating the market with its MUSE system, resulting in low revenue. The company is now focusing on Europe and China for distribution and conducting clinical trials for CFDA certification in China. Medigus liquidity problems have led to cutbacks in operations. The recent fundraising will keep the company operational for at least another year. The companys share price has dropped significantly since the offering.","partners":["Sinopharm"],"customers":null,"investors":null,"confidence":8,"key_topics":["GERD treatment","fundraising","market penetration","clinical trials","revenue"],"date_of_event":"March 26, 2017","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":"$7.5 million","structured_issues":["Investment","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Customers","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"MyAIlyhtoADbD9KHa2abeAuTQv33MpR8pgdGhY2ddXGD1Yxsq8FUFq","news_summary":"Medigus raises NIS 7.5m on Nasdaq - share plunges","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ba3a025b-4e8b-4c26-af5a-03035322dc0c","date":"Jun 28, 2016","link":"http://www.globes.co.il/en/article-layoffs-pay-cuts-at-medigus-1001135774","source":"www.globes.co.il","visible":1,"analysis":{"tags":"layoffs","company":"Medigus","layoffs":"substantial","summary":"Medigus has begun substantial layoffs of sales personnel in the US and employees at its Israel development center. The company is currently re-launching its product after the initial launch was deemed unready for the market. They are making progress in attaining reimbursement from medical insurance companies for patients using the device. However, the company needs a large amount of money to survive and will likely have to raise capital and seek strategic partnerships. Medigus principal shareholders include OrbiMed Advisors LLC, Senvest Management, Armistice Capital, and Migdal Insurance and Financial Holdings Ltd.","partners":null,"customers":null,"investors":["OrbiMed Advisors LLC","Senvest Management","Armistice Capital","Migdal Insurance and Financial Holdings Ltd."],"confidence":9,"key_topics":["layoffs","product launch","reimbursement","fundraising","strategic partnerships"],"date_of_event":"June 28, 2016","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Layoffs"],"acquisition_amount":null,"structuredIssuesShow":"#Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"iPjKlp3tqDIXPUag04VsDB06GiJISp6dY9VadVlYRiAPeom26kl037","news_summary":"Layoffs, pay cuts at Medigus","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1d45be56-ccb1-4fbd-a3ab-e79cc6f3be48","date":"Mar 20, 2016","link":"http://www.israel21c.org/incision-free-treatment-for-chronic-acid-reflux","source":"www.israel21c.org","visible":1,"analysis":{"tags":["medical-device","acid reflux","MUSE System"],"company":"Medigus","layoffs":null,"summary":"Medigus, a medical-device company based in Israel, has developed the MUSE (Medigus Ultrasonic Surgical Endostapler) System, an incision-free outpatient procedure to treat acid reflux. The procedure reconstructs the esophageal valve through the mouth, eliminating the need for surgery. The company has received FDA and CE approvals and has already been used in over 200 procedures in top-tier US facilities. Medigus has also signed a $17 million distribution deal in China and is looking to expand to Spain. The company is considering applying its technology to other gastrointestinal-tract procedures and is expecting strategic interest from other companies. Medigus sees 2016 as a pivotal year for its growth and aims to become a global organization while keeping its headquarters in Israel.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["acid reflux","MUSE System","medical-device","surgical procedure","global expansion"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"czNeVvOnpXeiIGVrDdivZ646YFsUBnDBqujCCZTlrhMRGJFpmP1qDS","news_summary":"Incision-free treatment for chronic acid reflux","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"57f0fe56-72ed-475e-a9d0-20d63428939b","date":"May 10, 2015","link":"http://www.globes.co.il/en/article-medigus-files-to-trade-on-nasdaq-1001035042","source":"www.globes.co.il","visible":1,"analysis":{"tags":"listing, non-invasive devices, heartburn","company":"Medigus Ltd.","layoffs":null,"summary":"Medical devices company Medigus Ltd. has filed a prospectus with the US Securities and Exchange Commission for listing its shares as American depository receipts. After the process is completed, the companys security will be listed on Nasdaq, allowing it to conduct financing rounds in the US. Medigus had NIS 2.6 million revenue in 2014, and its loss grew to NIS 22.6 million. The companys CEO stated that they are working towards getting their product accepted in the market as an alternative to conventional surgery. The American Medical Association has recommended that government insurance companies should include Mediguss procedure in their health baskets.","partners":null,"customers":null,"investors":"OrbiMed Advisors LLC","confidence":9,"key_topics":["Medigus","non-invasive devices","heartburn","listing","Nasdaq"],"date_of_event":"May 10, 2015","valuation_amount":"NIS 120 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FMy4PftWJKtzRfBEzGbqjcDxvxmWsIfoJStXALPDAFKw6E2utVcsoT","news_summary":"Medigus files to trade on Nasdaq","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2d835bc4-aea8-4c58-bb2c-5a68fbb85d90","date":"Jan 8, 2015","link":"http://nocamels.com/2015/01/medigus-receives-japanese-patent-for-scoutcam/","source":"nocamels.com","visible":1,"analysis":{"tags":"patent","company":"Medigus","layoffs":null,"summary":"Medigus, an Israeli company developing minimally invasive surgical tools, has been awarded a Japanese patent for its miniature camera, the micro ScoutCam. The patent, titled Small Diameter Video Camera Heads and Visualization Probes and Medical Devices Containing Them, became effective in December 2014 and will be valid until September 2030. Medigus has also applied for approval of this patent in the U.S., Europe, South Korea, and Israel.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Medigus","Japanese patent","micro ScoutCam","minimally invasive surgical tools","camera"],"date_of_event":"December 2014","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FGG8sYmCtrv0RfxlIYBtrmMBcBRqtCHMH5rxxWeeLMrkX2gdd37xfq","news_summary":"Medigus Receives Japanese Patent For ScoutCam","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"464a14c5-1330-415b-9377-d974036b1e8d","date":"Sep 12, 2014","link":"http://www.massdevice.com/medigus-raises-56m-touts-clinical-results-acid-reflux-device/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"funding, clinical results","company":"Medigus","layoffs":null,"summary":"Medical device maker Medigus closed a $5.6 million funding round with 5 backers. The companys MUSE clinical results were published in the journal Surgical Endoscopy, showing positive 6-month results in treating patients with gastroesophageal reflux disease. Medigus has also received FDA clearance for its next-gen MUSE technology and raised $11 million in a private placement round.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["funding","clinical results","MUSE device","gastroesophageal reflux disease","FDA clearance"],"date_of_event":"September 5, 2014","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5.6 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"0KNx1TR1br0zuqvEsDwfxqgLTVoC0u1UE71IcqCY7rQjeslka2WdVP","news_summary":"Medigus raises $5.6M, touts clinical results for acid reflux device","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9c72b052-d33a-435a-a044-68023bde23d1","date":"Aug 19, 2014","link":"http://nocamels.com/2014/08/medigus-created-the-worlds-smallest-camera-now-being-used-by-nasa-robots/","source":"nocamels.com","visible":1,"analysis":{"tags":"technology, space exploration","company":"Medigus","layoffs":null,"summary":"NASA has adopted Israeli company Medigus technology for a robot to inspect equipment in deep space. Medigus tiny camera, called the micro ScoutCam 1.2, will provide vision capabilities to the robot, allowing technicians on Earth to get a close-up look at equipment. The camera is the smallest in the world, with a 224 x 224 pixel resolution. The robot, called VIPIR, will be used on the International Space Station to test remote-repair technologies developed by NASA and the Canadian Space Agency.","partners":["NASA","European Automated Transfer Vehicle-5"],"customers":null,"investors":null,"confidence":8,"key_topics":["NASA","robot","inspection","equipment","camera"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"E7LgHrMhpE1K1ugGbjtUXh2LxWRnCKMskoGOPdYMCAfCcmNPb3O3ow","news_summary":"Medigus Created The World's Smallest Camera Now Being Used By NASA Robots","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b3435c6d-e8ad-45f8-ab46-42b43fdfe0b2","date":"Jun 30, 2014","link":"http://www.massdevice.com/acid-reflux-medigus-raises-11m-us-and-israeli-groups/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"investment","company":"Medigus","layoffs":null,"summary":"Medigus, an Israel-based device maker, has successfully closed an $11.1 million private placement funding round. The funding was split evenly between Israeli and overseas investors and will be used for general corporate activities. The company plans to expand the use of its MUSE system and enhance its position in the minimally invasive endosurgical market. Medigus expects to generate revenue this year from its FDA-cleared MUSE system for treating acid reflux. The company has previously received FDA clearance for its next-gen MUSE technology. Medigus has been experiencing growth, with previous funding rounds worth a total of $15 million.","partners":null,"customers":null,"investors":["Migdal Insurance Group","Sabby Management","Armistice Capital","Senvest","Orbimed"],"confidence":9,"key_topics":["Private placement funding","MUSE system","FDA clearance","Minimally invasive endosurgical market","Acid reflux treatment"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$11.1 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"fkpTUwvyc7No8ueazKHZKFuFhyMxvBPmZmxrruuiPxrY92fOt9xvTi","news_summary":"Acid reflux: Medigus raises $11M from U.S. and Israeli groups","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f2427dd7-3153-48d0-b768-0dac2f467759","date":"Mar 23, 2014","link":"http://www.globes.co.il/en/article-medigus-gets-fda-nod-for-upgraded-muse-system-1000926318","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical device","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has received FDA clearance for its next generation MUSE system, a minimally invasive tool for treating GERD. The system aims to reduce or eliminate GERD symptoms in patients, who are at higher risk of developing esophageal cancer. The clearance is a significant milestone for Medigus and positions the company for sustained, significant long-term growth. The new MUSE system is easier to use and has improved features, such as an improved graphical user interface and enhanced digital resolution. The surgical endoscope remains disposable for patient safety.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["FDA clearance","MUSE system","GERD","minimally invasive endosurgical tools","esophageal cancer"],"date_of_event":"March 23, 2014","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yfqEWQlJFBHfawrfs2vETcT7FVCXaLJgclRqirgxEFV1gqu4PQsNv2","news_summary":"Medigus gets FDA nod for upgraded MUSE system","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2285f585-a2cd-4930-9002-0dd8c06f42ca","date":"Oct 24, 2013","link":"http://www.massdevice.com/israels-medigus-raises-another-7m-support-acid-reflux-treatment/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"Funding, Expansion","company":"Medigus","layoffs":"Not mentioned","summary":"Israel-based medical device company, Medigus, has raised $7 million in a funding round through the sale of shares and options. The funding round saw participation from investors in the U.S. and Israel. The funds will be used to expedite Medigus’ penetration into the U.S and Europe markets and to support the enrollment of new patients into new and existing medical centers. Earlier this year, Medigus closed an $8 million private placement in support of its SRS Endoscopic system, a treatment for gastroesophageal reflux disease, which won FDA clearance for the U.S. market in May 2012.","partners":"Not mentioned","customers":"Not mentioned","investors":"Investors from the U.S and Israel","confidence":9,"key_topics":["Funding Round","Expansion","Medical Device","U.S Market","Europe Market"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"$7 million","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"ZWUVRw10xQAwjgjIbmjoPpocot6r65qL4THLSLGQEwfMaBuObQVjfh","news_summary":"Israel's Medigus raises another $7M in support of acid reflux treatment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dd0ef618-b5af-4f12-9208-92c421ff13a2","date":"Aug 13, 2013","link":"http://www.globes.co.il/en/article-1000871962","source":"www.globes.co.il","visible":1,"analysis":{"tags":"management changes","company":"Medigus Ltd.","layoffs":null,"summary":"Medigus Ltd. has appointed Christopher Rowland as CEO, replacing founder and current CEO Dr. Elazar Sonnenschein. Dr. Sonnenschein will become global COO and assist in the transition. The appointment is subject to approval by the companys shareholders. Medigus aims to become a market leader in minimally invasive medical markets and establish its SRS system as an alternative to more invasive surgical procedures. The company is at the forefront of the transition from invasive gastric surgery procedures to advanced minimally invasive treatment techniques. The SRS system allows treatment of chronic reflux through a one-time endoscopic procedure. The appointment of Chris Rowland is expected to support the companys growth and expansion globally.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["CEO appointment","global COO","sales and marketing infrastructure","SRS system","minimally-invasive procedures"],"date_of_event":"August 13, 2013","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wugMScFaUHxRpVk42fyzMur6peoXbTdOD0mmW9O9BnNsvFxmJ0gVWa","news_summary":"Medigus appoints Christopher Rowland as CEO","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":91,"techcommunityinvolvement":null,"mediagallery":[{"id":"af568d09-f8ca-4bac-b861-d42669d3de3d","timestamp":"2017-12-01 15:02:43.000000","resources_type":2,"resources_title":"","resources_file_name":"lp_3EdzG3vk","alt":"","imageurl":"https://img.youtube.com/vi/lp_3EdzG3vk/0.jpg","url":"http://youtu.be/lp_3EdzG3vk"},{"id":"fe90c97c-e7bd-4f03-9636-b721680cd046","timestamp":"2015-01-19 13:53:29.000000","resources_type":2,"resources_title":"","resources_file_name":"mcY_UBzdC6I","alt":"","imageurl":"https://img.youtube.com/vi/mcY_UBzdC6I/0.jpg","url":"http://youtu.be/mcY_UBzdC6I"},{"id":"bdbaad24-bf99-45ad-96dd-4ecacb1a758b","timestamp":"2014-07-06 17:36:11.000000","resources_type":2,"resources_title":"MediGus innovative endoscopy system for the treatment of GERD","resources_file_name":"L5-WJg-GnMs","alt":"MediGus innovative endoscopy system for the treatment of GERD logo","imageurl":"https://img.youtube.com/vi/L5-WJg-GnMs/0.jpg","url":"http://youtu.be/L5-WJg-GnMs"}],"tags":["sensors","imaging","minimally-invasive","doctors","surgical-instruments","gastroenterology","medical-devices","chronic-disease","ultrasound","endoscopy","surgeons","optronics","treatments","defense","aerospace","medical-technologies"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puanf0LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4Z8IDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfYioYLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2G","B2B"],"productstage":"Released","products":["micro ScoutCam","MUSE"],"geomarkets":["Germany","China","United States","Europe","Azerbaijan","Turkey","Spain","Georgia"],"targetmarkets":[],"marketcapital":6533304,"marketcapitaldate":"2025-08-01T13:09:08.000Z","funding":{"investors":7,"lastfunding":"$8.4M","totalrounds":10,"fundingstage":"Public","totalfunding":"$77M","publicinvestors":7,"lastpublicfunding":8400000,"totalpublicrounds":10,"totalpublicfunding":77000000},"team":[{"name":"Liron Carmel","email":"liron.carmel@medigus.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OLY2p4KDA","bounced":false,"claimed":0,"founder":0,"urlname":"liron-carmel","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgou64hAoM","position":"CEO","last_name":"Carmel","claimtoken":"qz0SDHHlpwZJLAFnfkI7k3zvKdEdSXORuDgVsbJ694WsEwpAIcmkJf","first_name":"Liron","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-10-11 15:40:49.000000","initials":"LC","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Elazar Sonnenschein","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoMr2wJsKDA","bounced":false,"claimed":0,"founder":1,"urlname":"elazar-sonnenschein","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgysDkigoM","position":"Founder","last_name":"Sonnenschein","claimtoken":"872b66aa6b00c290f1a80cf3ff30a20ddbac73e79fa5ed3f5ceaf61a4101e8ed","first_name":"Elazar","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/elazar-sonnenschein-14241/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2017-12-01 15:06:11.000000","initials":"ES","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Lior Lurie","email":"lior.lurie@medigus.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoLnp07QIDA","bounced":true,"claimed":0,"founder":0,"urlname":"lior-lurie-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgxbTSywgM","position":"Business Development Manager","last_name":"Lurie","claimtoken":"6587a914853ccad30bbb07979ea4f552060f88746d2510de9847fed8f3b6ecaf","first_name":"Lior","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/lior-lurie-5300131b/","unsubscribed":false,"is_activeuser":1,"additionalemail":"lior@medigus.com","claimedemaildate":"2020-08-23 10:25:39.000000","initials":"LL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2019-10-28T00:00:00.000Z","crunchbaseid":"medigus","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2014-07-06T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Ayelet Beazley","affiliatedOrganizations":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkIzj8oIJDA","name":"Charging Robotics","type":"Startup","hidden":false,"fullurl":"/company_page/charging-robotics","logokey":"$NlACMWO4WKPjaBOP4uaI1RfG1HK79osgMySOQF9dw8aydEfIwgNdKH.png","logourl":"https://storage.googleapis.com/clean-finder-353810/$NlACMWO4WKPjaBOP4uaI1RfG1HK79osgMySOQF9dw8aydEfIwgNdKH.png","onClick":"","visibilityClassName":"","visibilityTooltip":""}],"timeline":[{"id":"yZKMNfLZeqogQS1cOYLUZPWb8kxTrYUnVjwS8Lv3kZy3XT02HUnaZl","date":"Apr 2025","amount":"Undisclosed","source":"","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"Metagramm Software","acquiredcompany_mna_id":"yRlPGi5PyDNjlAuyz3DfdpF7pQw4LbPjogChy0QVZteEPVodARTUgE","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/metagramm-software","acquiredcompany_mna_logokey":"$ivtCgskkZDpqzwmIbAeL3KifNepYiN0TfmAwy6MsATVUBE2U51aZyS.webp","acquiredcompany_mna_urlname":"/company_page/metagramm-software","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$ivtCgskkZDpqzwmIbAeL3KifNepYiN0TfmAwy6MsATVUBE2U51aZyS.webp","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"VK6ZaFKgXKdPumcw9cbJefvZGTIwwgys7j1NJaI64TMobN5u94CXw6","date":"Jan 2022","amount":"$4.32M","source":"https://www.suasnews.com/2022/01/delta-drone-international-asxdlt-to-divest-parazero-for-6-million-in-cash/","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"ParaZero","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLH2v4cJDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/parazero","acquiredcompany_mna_logokey":"$8Udz1gsfPZ7D8HsG5eqKtRY7KO3jJFpTRjNXmAs7NHizNDErNbKhk0","acquiredcompany_mna_urlname":"/company_page/parazero","acquiredcompany_mna_homepage":"https://parazero.com","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$8Udz1gsfPZ7D8HsG5eqKtRY7KO3jJFpTRjNXmAs7NHizNDErNbKhk0","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":4320000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCLu7OcCgw","date":"Mar 2021","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2021/01/11/2156285/0/en/Medigus-Prices-8-4Million-Underwritten-Public-Offering-of-American-Depositary-Shares.html","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$8.4M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":8400000,"valuationnumber":null},{"id":"LGctF7XH0xild7n6E3q4b4NxNwnbeZ5KUBmY62WpRNNU5GW8JBfT4R","date":"Jan 2021","amount":"Undisclosed","source":"https://finance.yahoo.com/news/medigus-closes-8-4-million-151300302.html","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODDxrnNCgw","date":"Dec 2020","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2020/12/04/2139988/0/en/Medigus-Closes-13-Million-Underwritten-Public-Offering-of-ADSs.html","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$13M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":13000000,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODVy5-MCQw","date":"Oct 2020","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2020/10/16/2109829/0/en/Medigus-to-Acquire-Control-of-Automated-Online-Offline-Ticketing-Platform-Company-Eventer.html","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Eventer","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPX2koYLDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/eventer","acquiredcompany_mna_logokey":"$cmwPU6bFuyyNHQ2XfT4uuUK7V52GiNZXwFew6KPJSrvRF6C4fI3Nvg","acquiredcompany_mna_urlname":"/company_page/eventer","acquiredcompany_mna_homepage":"https://www.eventer.co.il","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$cmwPU6bFuyyNHQ2XfT4uuUK7V52GiNZXwFew6KPJSrvRF6C4fI3Nvg","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD717DpCAw","date":"Jun 2019","amount":"$2.76M","source":"http://www.medigus.com/investor-relations/press-releases/news-2019/356-medigus-to-invest-5-million-in-algomizer-group","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Linkury","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6f54MLDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/linkury","acquiredcompany_mna_logokey":"$s2TL6aiN29PzgueNKrfxSgwleEKQpzY0rY6OwJY8cbpp2GBVdbXyOD","acquiredcompany_mna_urlname":"/company_page/linkury","acquiredcompany_mna_homepage":"http://www.linkury.com/","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$s2TL6aiN29PzgueNKrfxSgwleEKQpzY0rY6OwJY8cbpp2GBVdbXyOD","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":2760000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjd6PCAw","date":"Jul 2018","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2018/07/23/1540853/0/en/Medigus-Announces-Closing-of-10-Million-Public-Offering.html","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$10M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":10000000,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCIw4rGCww","date":"Jul 2015","amount":"Undisclosed","source":"https://www.globenewswire.com/en/news-release/2015/07/16/752656/28091/en/MEDIGUS-ANNOUNCES-COMPLETION-OF-7-1-MILLION-PUBLIC-OFFERING.html","ticker":"XYLO","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$7.1M","stockexchange":"NASDAQ","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCIutD_CQw","stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":7100000,"valuationnumber":null},{"id":"V97B3vSChAAxzNd4TyfohY2QyOiowPZPwVtQG5obCRzbXtZzEvrzLg","date":"Sep 2014","amount":"$5.6M","source":"https://www.massdevice.com/medigus-raises-56m-touts-clinical-results-acid-reflux-device/","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"M3YGVUrfAufAXACx8rlKQilkqdWJdhv2gG7Cy7o0jDp0v1YDxrBlkl","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmqmmCAw","date":"Jun 2014","amount":"$11.1M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sabby Management","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/sabby-management","logokey":null,"tagline":"","urlname":"/investor_page/sabby-management","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk2rOBCgw","fundingtype":"Institutional Investor","leadpartner":null,"investmentid":"19c04bee-e00f-4f1c-a002-22d9020c820f","fundingsubtype":"Institutional Investor","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"384d2ee0-efbf-4233-8600-c1eeb2912495","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","leadcaption":"","followupcaption":""},{"name":"Senvest Capital","type":"Other","amount":0,"hidden":false,"country":"Canada","fullurl":"/company_page/senvest-capital","logokey":"$HS6nVDE09YKDcD1H6R3UPyVTY1qkpzQj80Su8uE4Jd962Ou9pSGgyf","tagline":"","urlname":"/company_page/senvest-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkmseaCww","fundingtype":"Other","leadpartner":null,"investmentid":"c8bd8ac7-2708-4d42-baf6-14333bf962e6","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$HS6nVDE09YKDcD1H6R3UPyVTY1qkpzQj80Su8uE4Jd962Ou9pSGgyf","leadcaption":"","followupcaption":""},{"name":"Armistice Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/armistice-capital","logokey":"$SPbLgAIIVUg7cY2IxLbP0BiwNeSRbIbsKiXPtjaCAT4UjwsroGuazj","tagline":"","urlname":"/investor_page/armistice-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqKzCCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d711bc92-5de8-42e7-9674-d1b912cc5921","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SPbLgAIIVUg7cY2IxLbP0BiwNeSRbIbsKiXPtjaCAT4UjwsroGuazj","leadcaption":"","followupcaption":""},{"name":"Migdal Insurance and Financial Holdings","type":"Other","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/migdal-insurance-and-financial-holdings","logokey":"$ZQpUoB0f1AEiAJHRQhz0UNrTGQxYPNx3w1WzXv01jkvMVtZ44iLHpq","tagline":"","urlname":"/company_page/migdal-insurance-and-financial-holdings","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEvP6PCww","fundingtype":"Other","leadpartner":null,"investmentid":"db5b0726-5178-4bfd-96f0-86397fd2b0a7","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZQpUoB0f1AEiAJHRQhz0UNrTGQxYPNx3w1WzXv01jkvMVtZ44iLHpq","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":11100000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"ISPdTdeQO7BO9L89qzzOzMoHKKhCTPODAKFesR52W6NpgHrqYHPN2I","date":"Oct 2013","amount":"$7M","source":"https://www.massdevice.com/israels-medigus-raises-another-7m-support-acid-reflux-treatment/","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"07T9jtp8pD93KjDjoGvYjxzNtnn2RYs9irpW5ixHqogNkQyJmF0bVm","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"9ocFRghRA6BOn8XcKgwQWtRFH1lQ2FxZ3tWf92b8RTSG5AvhgiHGal","date":"Mar 2013","amount":"$8M","source":"https://www.massdevice.com/israeli-acid-reflux-treatment-group-closes-8m-private-placement/","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"eNwEyjgooR5Zv3ppi91Tp6vNUYajGKDGCiBZ93V5cR9crr8aX6X3FC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"e8gZ1F1qnh9vXDcdK0XuiaNEHpdHVrZyCgoPtcMJfYJzliNQtFm0Ux","date":"May 2010","amount":"Undisclosed","source":"https://ratiotech.co.il/portfolio/","eventtype":"FundingRoundEvent","investment":[{"name":"Ratio Technologies","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ratio-technologies","logokey":"$PLkFcndUX7cwRrRHWDYYXwg29Smj1EvywzgeKw2pberGDg4jX1F8p7","tagline":null,"urlname":"/investor_page/ratio-technologies","isisraeli":1,"investorid":"67VpLYXRy2rnHNPzR0lqfo7bK1RsqfE66PASPHqUsjWM12qmoek23z","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"HrfWIbg3qAh2rC9MYQP9KwwkZxJ8CTPixUGsIZ8IPGQtpvuBDkZU9R","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$PLkFcndUX7cwRrRHWDYYXwg29Smj1EvywzgeKw2pberGDg4jX1F8p7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCojdqBCQw","date":"Mar 2006","amount":"Undisclosed","source":"","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$6.8M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":6800000,"valuationnumber":null}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/1999","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Xylo Technologies","logourl":"https://storage.googleapis.com/clean-finder-353810/$CEWwmu7lZFOsr6UiL4VFq0cUUUGgDI0bMB2NiSqr7IwTUzTi9aKOS0","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$CEWwmu7lZFOsr6UiL4VFq0cUUUGgDI0bMB2NiSqr7IwTUzTi9aKOS0","seoabout":"Medigus is a technology-based company engaged in advancing innovative solutions for large-scale market applications.\r\n\r\nThe activities carried out by Medig...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":1,"name":"Industrial Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puanf0LDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Enterprise & Professional Services","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA","classificationName":"targetcustomer"},{"depth":2,"name":"Enterprises","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfYioYLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Industrial Manufacturing","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Discrete Industries","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","classificationName":"targetcustomer"},{"depth":3,"name":"Automotive","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4Z8IDA","classificationName":"targetcustomer"},{"depth":2,"name":"Industrial Equipment","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsJDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Enterprise & Professional Services#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA","SectorClassificationModel>Industrial Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puanf0LDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA>Automotive#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4Z8IDA","IndustryClassificationModel>Enterprise & Professional Services#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA>Enterprises#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfYioYLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Industrial Equipment#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","TechnologyClassificationModel>Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|1:>SectorClassificationModel/Industrial Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puanf0LDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Enterprise & Professional Services#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA|2:>IndustryClassificationModel>Enterprise & Professional Services#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA/Enterprises#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfYioYLDA|1:>IndustryClassificationModel/Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA|2:>IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA/Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA|3:>IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA/Automotive#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4Z8IDA|2:>IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA/Industrial Equipment#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsJDA|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|1:>TechnologyClassificationModel/Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]},{"title":"Industrial Technologies","key":"0-1","path":"SectorClassificationModel>Industrial Technologies"}],"targetCustomer":[{"title":"Enterprise & Professional Services","key":"0-0","path":"IndustryClassificationModel>Enterprise & Professional Services","children":[{"title":"Enterprises","key":"0-0-0","path":"IndustryClassificationModel>Enterprise & Professional Services>Enterprises"}]},{"title":"Industrial Manufacturing","key":"0-1","path":"IndustryClassificationModel>Industrial Manufacturing","children":[{"title":"Discrete Industries","key":"0-1-0","path":"IndustryClassificationModel>Industrial Manufacturing>Discrete Industries","children":[{"title":"Automotive","key":"0-1-0-0","path":"IndustryClassificationModel>Industrial Manufacturing>Discrete Industries>Automotive"}]},{"title":"Industrial Equipment","key":"0-1-1","path":"IndustryClassificationModel>Industrial Manufacturing>Industrial Equipment"}]},{"title":"Healthcare & Life Sciences","key":"0-2","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-2-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-2-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Sensing","key":"0-0","path":"TechnologyClassificationModel>Sensing"},{"title":"Simulation & Imaging","key":"0-1","path":"TechnologyClassificationModel>Simulation & Imaging"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":1,"name":"Industrial Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puanf0LDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Enterprise & Professional Services","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8IDA","classificationName":"targetcustomer"},{"depth":2,"name":"Enterprises","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfYioYLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Industrial Manufacturing","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Discrete Industries","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","classificationName":"targetcustomer"},{"depth":3,"name":"Automotive","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4Z8IDA","classificationName":"targetcustomer"},{"depth":2,"name":"Industrial Equipment","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsJDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics","Industrial Technologies"],"coreTechnology":["Sensing","Simulation & Imaging"],"targetCustomer":["Enterprise & Professional Services","Enterprises","Industrial Manufacturing","Discrete Industries","Automotive","Industrial Equipment","Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCLu7OcCgw","date":"Mar 2021","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2021/01/11/2156285/0/en/Medigus-Prices-8-4Million-Underwritten-Public-Offering-of-American-Depositary-Shares.html","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$8.4M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":8400000,"valuationnumber":null},{"id":"LGctF7XH0xild7n6E3q4b4NxNwnbeZ5KUBmY62WpRNNU5GW8JBfT4R","date":"Jan 2021","amount":"Undisclosed","source":"https://finance.yahoo.com/news/medigus-closes-8-4-million-151300302.html","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODDxrnNCgw","date":"Dec 2020","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2020/12/04/2139988/0/en/Medigus-Closes-13-Million-Underwritten-Public-Offering-of-ADSs.html","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$13M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":13000000,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjd6PCAw","date":"Jul 2018","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2018/07/23/1540853/0/en/Medigus-Announces-Closing-of-10-Million-Public-Offering.html","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$10M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":10000000,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCIw4rGCww","date":"Jul 2015","amount":"Undisclosed","source":"https://www.globenewswire.com/en/news-release/2015/07/16/752656/28091/en/MEDIGUS-ANNOUNCES-COMPLETION-OF-7-1-MILLION-PUBLIC-OFFERING.html","ticker":"XYLO","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$7.1M","stockexchange":"NASDAQ","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCIutD_CQw","stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":7100000,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCojdqBCQw","date":"Mar 2006","amount":"Undisclosed","source":"","ticker":"MDGS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$6.8M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":6800000,"valuationnumber":null}],"privateequityfunding":[{"id":"V97B3vSChAAxzNd4TyfohY2QyOiowPZPwVtQG5obCRzbXtZzEvrzLg","date":"Sep 2014","amount":"$5.6M","source":"https://www.massdevice.com/medigus-raises-56m-touts-clinical-results-acid-reflux-device/","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"M3YGVUrfAufAXACx8rlKQilkqdWJdhv2gG7Cy7o0jDp0v1YDxrBlkl","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmqmmCAw","date":"Jun 2014","amount":"$11.1M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Sabby Management","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/sabby-management","logokey":null,"tagline":"","urlname":"/investor_page/sabby-management","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk2rOBCgw","fundingtype":"Institutional Investor","leadpartner":null,"investmentid":"19c04bee-e00f-4f1c-a002-22d9020c820f","fundingsubtype":"Institutional Investor","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"384d2ee0-efbf-4233-8600-c1eeb2912495","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","leadcaption":"","followupcaption":""},{"name":"Senvest Capital","type":"Other","amount":0,"hidden":false,"country":"Canada","fullurl":"/company_page/senvest-capital","logokey":"$HS6nVDE09YKDcD1H6R3UPyVTY1qkpzQj80Su8uE4Jd962Ou9pSGgyf","tagline":"","urlname":"/company_page/senvest-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkmseaCww","fundingtype":"Other","leadpartner":null,"investmentid":"c8bd8ac7-2708-4d42-baf6-14333bf962e6","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$HS6nVDE09YKDcD1H6R3UPyVTY1qkpzQj80Su8uE4Jd962Ou9pSGgyf","leadcaption":"","followupcaption":""},{"name":"Armistice Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/armistice-capital","logokey":"$SPbLgAIIVUg7cY2IxLbP0BiwNeSRbIbsKiXPtjaCAT4UjwsroGuazj","tagline":"","urlname":"/investor_page/armistice-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqKzCCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d711bc92-5de8-42e7-9674-d1b912cc5921","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SPbLgAIIVUg7cY2IxLbP0BiwNeSRbIbsKiXPtjaCAT4UjwsroGuazj","leadcaption":"","followupcaption":""},{"name":"Migdal Insurance and Financial Holdings","type":"Other","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/migdal-insurance-and-financial-holdings","logokey":"$ZQpUoB0f1AEiAJHRQhz0UNrTGQxYPNx3w1WzXv01jkvMVtZ44iLHpq","tagline":"","urlname":"/company_page/migdal-insurance-and-financial-holdings","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEvP6PCww","fundingtype":"Other","leadpartner":null,"investmentid":"db5b0726-5178-4bfd-96f0-86397fd2b0a7","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZQpUoB0f1AEiAJHRQhz0UNrTGQxYPNx3w1WzXv01jkvMVtZ44iLHpq","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":11100000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"ISPdTdeQO7BO9L89qzzOzMoHKKhCTPODAKFesR52W6NpgHrqYHPN2I","date":"Oct 2013","amount":"$7M","source":"https://www.massdevice.com/israels-medigus-raises-another-7m-support-acid-reflux-treatment/","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"07T9jtp8pD93KjDjoGvYjxzNtnn2RYs9irpW5ixHqogNkQyJmF0bVm","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"9ocFRghRA6BOn8XcKgwQWtRFH1lQ2FxZ3tWf92b8RTSG5AvhgiHGal","date":"Mar 2013","amount":"$8M","source":"https://www.massdevice.com/israeli-acid-reflux-treatment-group-closes-8m-private-placement/","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"eNwEyjgooR5Zv3ppi91Tp6vNUYajGKDGCiBZ93V5cR9crr8aX6X3FC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"e8gZ1F1qnh9vXDcdK0XuiaNEHpdHVrZyCgoPtcMJfYJzliNQtFm0Ux","date":"May 2010","amount":"Undisclosed","source":"https://ratiotech.co.il/portfolio/","eventtype":"FundingRoundEvent","investment":[{"name":"Ratio Technologies","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ratio-technologies","logokey":"$PLkFcndUX7cwRrRHWDYYXwg29Smj1EvywzgeKw2pberGDg4jX1F8p7","tagline":null,"urlname":"/investor_page/ratio-technologies","isisraeli":1,"investorid":"67VpLYXRy2rnHNPzR0lqfo7bK1RsqfE66PASPHqUsjWM12qmoek23z","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"HrfWIbg3qAh2rC9MYQP9KwwkZxJ8CTPixUGsIZ8IPGQtpvuBDkZU9R","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$PLkFcndUX7cwRrRHWDYYXwg29Smj1EvywzgeKw2pberGDg4jX1F8p7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[{"id":"yZKMNfLZeqogQS1cOYLUZPWb8kxTrYUnVjwS8Lv3kZy3XT02HUnaZl","date":"Apr 2025","amount":"Undisclosed","source":"","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"Metagramm Software","acquiredcompany_mna_id":"yRlPGi5PyDNjlAuyz3DfdpF7pQw4LbPjogChy0QVZteEPVodARTUgE","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/metagramm-software","acquiredcompany_mna_logokey":"$ivtCgskkZDpqzwmIbAeL3KifNepYiN0TfmAwy6MsATVUBE2U51aZyS.webp","acquiredcompany_mna_urlname":"/company_page/metagramm-software","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$ivtCgskkZDpqzwmIbAeL3KifNepYiN0TfmAwy6MsATVUBE2U51aZyS.webp","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"VK6ZaFKgXKdPumcw9cbJefvZGTIwwgys7j1NJaI64TMobN5u94CXw6","date":"Jan 2022","amount":"$4.32M","source":"https://www.suasnews.com/2022/01/delta-drone-international-asxdlt-to-divest-parazero-for-6-million-in-cash/","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"ParaZero","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLH2v4cJDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/parazero","acquiredcompany_mna_logokey":"$8Udz1gsfPZ7D8HsG5eqKtRY7KO3jJFpTRjNXmAs7NHizNDErNbKhk0","acquiredcompany_mna_urlname":"/company_page/parazero","acquiredcompany_mna_homepage":"https://parazero.com","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$8Udz1gsfPZ7D8HsG5eqKtRY7KO3jJFpTRjNXmAs7NHizNDErNbKhk0","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":4320000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODVy5-MCQw","date":"Oct 2020","amount":"Undisclosed","source":"https://www.globenewswire.com/news-release/2020/10/16/2109829/0/en/Medigus-to-Acquire-Control-of-Automated-Online-Offline-Ticketing-Platform-Company-Eventer.html","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Eventer","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPX2koYLDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/eventer","acquiredcompany_mna_logokey":"$cmwPU6bFuyyNHQ2XfT4uuUK7V52GiNZXwFew6KPJSrvRF6C4fI3Nvg","acquiredcompany_mna_urlname":"/company_page/eventer","acquiredcompany_mna_homepage":"https://www.eventer.co.il","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$cmwPU6bFuyyNHQ2XfT4uuUK7V52GiNZXwFew6KPJSrvRF6C4fI3Nvg","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD717DpCAw","date":"Jun 2019","amount":"$2.76M","source":"http://www.medigus.com/investor-relations/press-releases/news-2019/356-medigus-to-invest-5-million-in-algomizer-group","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Linkury","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6f54MLDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/linkury","acquiredcompany_mna_logokey":"$s2TL6aiN29PzgueNKrfxSgwleEKQpzY0rY6OwJY8cbpp2GBVdbXyOD","acquiredcompany_mna_urlname":"/company_page/linkury","acquiredcompany_mna_homepage":"http://www.linkury.com/","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$s2TL6aiN29PzgueNKrfxSgwleEKQpzY0rY6OwJY8cbpp2GBVdbXyOD","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":2760000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"others":[]}}